Gefitinib (ZD1839)

Catalog No.S1025

Gefitinib (ZD1839) Chemical Structure

Molecular Weight(MW): 446.90

Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Size Price Stock Quantity  
In DMSO USD 191 In stock
USD 147 In stock
USD 270 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 91 Publications

12 Customer Reviews

  • Perturbation of EGFR by its ligand EGF and gefitinib (ZD-1839 Iressat; inhibits EGFR) produces opposite responses in the predicted EGFR target genes SOCS2 and NR2E1.

    Mol Syst Biol 2011 7, 486. Gefitinib (ZD1839) purchased from Selleck.

    Effects of shRNA-mediated RECK depletion on EGFR signaling in MEFs. (a) Immunoblotting (IB) of the indicated proteins in wild-type MEFs transduced with the indicated shRNAs and cultured for 48 h in the presence of 0.1% dimethyl sulfoxide (DMSO; vehicle) or 1 mM gefitinib (S1025, Selleck Chemicals,Houston, TX, USA). (b) Immunoprecipitation from whole lysates of cells from panel a with an anti-phosphorylated tyrosine (pTyr) antibody. Precipitates from 500 mg protein in whole cell lysates (upper) or 20 mg protein in whole cell lysates (lower) were analyzed by IB with anti-EGFR antibody.

    Oncogene 2010 30, 737-750. Gefitinib (ZD1839) purchased from Selleck.

  • (B–C) LNCaP (B) and LNCaP-AI (C) cells were transiently transfected with sPLA2-IIa(-800)-Luc (0.5 μg). The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 lM) and Bortezomib (20 μM) without or with EGF (100 ng/ml) for 24 h. Luciferase assay was performed according to a standard protocol with Renilla luciferase as an internal control. Data are presented as the mean (±SD) of duplicate values of a representative experiment that was independently repeated for five times.

    Carcinogenesis 2010 31, 1948–1955 . Gefitinib (ZD1839) purchased from Selleck.

    LNCaP-AI cells were starved in 1% stripped medium for 24 h. The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 μM) and Bortezomib (20 μM) for 24 h. Cell culture medium was collected from each sample and subjected to ELISA for sPLA2-IIa. The condition medium samples were diluted 10 times for ELISA. Average of duplicate samples was converted to nanogram per milliliter against standard curve. The data represent one of five repeated experiments.

     

     

    Carcinogenesis 2010 31, 1948–1955. Gefitinib (ZD1839) purchased from Selleck.

  • Susceptibility of lung cancer cells to cytolytic activity of NK-92 cells after treatment with EGFR inhibitors. Three lung cancer cells were untreated (open circle) or treated with 10 μM erlotinib or gefitinib (black filled square or black filled triangle) for 24 hours. The lung cancer cells were cocultured with NK-92 cells at indicated effector to target ratio (E:T ratio). To determine the specificity of NKG2D-mediated cytolysis of lung cancer cells, NK-92 cells were preincubated with blocking mAb against NKG2D before the assay (gray filled square and triangle) and correspond-ing isotype mAb (open square and triangle).

    J Immunother 2011 34(4), 372-81. Gefitinib (ZD1839) purchased from Selleck.

    Suppression of EGFR signaling by Gefitinib is dose dependent and non- toxic at millimolar concentrations.Results from plaque reduction tests of Hep2 cells infected with VACV(12.5pfu/well) treated with a serial dilution of Gefitinib (1000-0.01 m) and analyzed for (A)proliferation as indicator of cytotoxicity,(B) IC50 of plaque size inhibition, (C)dose dependent inhibition of EGFR-ERK1/2signaling and VACV proteins by Western blot analysis (pEGFR detection was obtained from a different experiment with identicals ettings) and (D)dose dependent inhibition of orthopoxvirus genome replication by real-time PCR.Untreated VACV infectedcells and uninfected cells are shown as controls in the right panel.

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

  • A circular zone of EGFR activated but uninfected cells facilitate virus induced plaque development , efficiently blocked by Gefitinib. (A)Immun of luorescent staining of aplaque reduction tests with Hep2 cells 24,48,72 and 96 h after VACV infection (6.25pfu/chamber). VACV infected cells(green) were visualized by human IgG directed to orthopoxviruses (VIG) detected with a secondary FITC labelled antibody. Uninfected cells with activated EGFR signaling(red) are detected with a secondary Cy3labelled antibody. Positive cells for both , VACV and phosphorylated EGFR are shown in yellow(merge). Cellular nuclei are counterstained with DAPI. (B)Immunofluorescent staining of a plaque reduction test as described for (A) and treated with three different Gefitinib concentrations (1000 nM, 1 nM, and 0.01 nM) . The test was analyzed 96h afterVACV infection.Uninfected cells are shown as controls. Magnification100×.(For interpretation of the references to color in this figure legend , the reader is referred to the web version of the article.)

     

     

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

    The EGF-dependent increased association of PCM1 and AZI1 requires EGFR kinase activity. ZD1839 (Iressa)—EGFR tyrosine kinase inhibitor.

    Mol Biosyst 2011 7, 3223-33. Gefitinib (ZD1839) purchased from Selleck.

  • Reduction of GPER expression in HCC1806 cells after treatment with gefitinib. (A) Concentration dependence. HCC1806 cells were treated with 50-500 nM gefitinib for 48 h. GPER was detected by western blotting. (B) Time dependence. HCC1806 cells were treated with 200 nM gefitinib for 24-96 h. ap<0.05 vs. control; bp<0.001 vs. control. Mean values and SE of three independent experiments are shown. (C) Representative western blotting of concentration dependence. (D) Representative western blotting of time dependence

    Oncol Rep, 2017, 37(2):1212-1218. Gefitinib (ZD1839) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 215496. Gefitinib (ZD1839) purchased from Selleck.

  • Breast cancer cells were pretreated with 100ng/ml EGF for 15 min and then treated with the indicated concentrations of  Gefitinib for 24 hours.

     

     

    2010 Dr. Zhang of Tianjin Medical University. Gefitinib (ZD1839) purchased from Selleck.

    MTT assay result. 0-500nM Gefitinib treated with H1299, H358, H25 and HCC827 cell lines by 72h, Proliferation rate was tested.

     

     

    2010 Dr. Vicky Tin from University of Hong Kong. Gefitinib (ZD1839) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Features A potent EGFR tyrosine kinase inhibitor.
Targets
Tyr1173 (NR6W cells) [1] Tyr1173 (NR6wtEGFR cells) [1] Tyr992 (NR6wtEGFR cells) [1] Tyr992 (NR6W cells) [1]
26 nM 37 nM 37 nM 57 nM
In vitro

Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both the high and low-EGFR-expressing cell lines including NR6, NR6M and NR6W cell lines. The phosphorylation sites Tyr1173 and Tyr992 are less sensitive requiring higher concentrations of Gefitinib for inhibition. Gefitinib effectively blocks the phosphorylation of PLC-γ, with IC50 of 27nM, in NR6W cells. The NR6wtEGFR and NR6M cell lines has low levels of PLC-γ phosphorylation but the level in the NR6M cell line is more resistant to inhibition by Gefitinib with IC50 of 43 nM and 369 nM, respectively. Gefitinib inhibits Akt phosphorylations, with IC50 of 220 and 263nM, in the low-EGFR- and -EGFRvIII-expressing cell lines, respectively. Gefitinib in the dose range from 0.1 to 0.5μM significantly facilitates, rather than abrogates, colony formation of NR6M cells. However, at a concentration of 2 μM Gefitinib completely blocks NR6M colony formation. Gefitinib rapidly and in a dose-dependent manner inhibits EGFR and ERK phosphorylation up to 72 hours after EGF stimulation in both the high- and low-EGFR-expressing cell lines. [1] Gefitinib is the monolayer growth of these EGF-driven untransformed MCF10A cells with an IC50 of 20 nM. [2] The combination of Gefitinib (0.2 μM and 0.5 μM) with irradiation lead to a significant growth inhibition in LoVo cells, compared with radiation alone.. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KB MorOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvJTWM2OD1yLkC1OEDPxE1? MXyxOlUyPjR5Mx?=
NIH3T3 NVTTbmpGTnWwY4Tpc44hSXO|YYm= NEf2VI8xNjJizszN MmTzNkBp M36zNGROW09? NYXkNJBFUW6qaXLpeIlwdiCxZjDFS2Yhe3SrbYXsZZRm\CCqdX3hckBmemKEMTDheZRweGixc4Doc5J6dGG2aX;uJJdqfGhiSVO1NEBw\iByLkCxOFQh|ryP M3OySlE3PDhyMki0
COS7 M4TlN2Z2dmO2aX;uJGF{e2G7 NYXPUJZkQTZizszN NFLicHNKdmirYnn0bY9vKG:oIHj1cYFvKEqDS{KgWlYyP0ZibYX0ZY51KGW6cILld5Nm\A>? NGjTOY4yPzF5OEeyNi=>
A549 M1zqfmN6fG:2b4jpZ{BCe3OjeR?= MVS5OkBp MVHEUXNQ M3[3R2lEPTB;MUOuOVkh|ryP M2rpfVE5OzF|OEC3
K562 MmjVR5l1d3SxeHnjJGF{e2G7 M4e4fFk3KGh? M4nvZWROW09? NIjaOY9KSzVyPUmuN|Yh|ryP MkPSNVg{OTN6MEe=
MDA-MB-231 M2jCRmN6fG:2b4jpZ{BCe3OjeR?= M{XkUVk3KGh? Ml7RSG1UVw>? NGS1WmFKSzVyPUO2MlYyKM7:TR?= M4G2Z|E5OzF|OEC3
MOLT4 MkWyR5l1d3SxeHnjJGF{e2G7 MXq5OkBp M17IZWROW09? MWjJR|UxRTF3LkCyJO69VQ>? MV2xPFMyOzhyNx?=
MCF7 M1i4bmN6fG:2b4jpZ{BCe3OjeR?= MXy1NEDPxE1? NYq4OIJPPzJiaB?= M2OxbWlEPTB;MUKuNFUh|ryP NGrwblEyQDd5MUixPS=>
BT474 MlzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEG0eVA4OiCq M{P0TmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQmS0O|Qh[2WubIOgc5ZmemW6cILld5NqdmdiRWLCZlIhf2m2aDDFR|UxKG:oIECuN{DPxE1? MlXHNVkxOjh2MkS=
HN5 NIrETlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYq3NkBp M1XOT2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSF61JINmdGy|IH;2[ZJmgHC{ZYPzbY5oKEWJRmKge4l1cCCHQ{WwJI9nKDBwMEGg{txO NE\SenIyQTB{OESyOC=>
BA/F3 NU[3UpQyS3m2b4TvfIlkKEG|c3H5 M3HEXlczKGh? NF7zR5FEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIFXHSnIhVDh3OGKgcZV1[W62IIfpeIghUUN3MDDv[kAxNjBzMEig{txO NEXtZ4wyQTJ|OUKyPS=>
NIH3T3 MnLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3rTOVczKGh? MnPyS5Jwf3SqIHnubIljcXSrb36gc4YhdW:3c3WgUmlJNzOWMzDj[YxteyCneIDy[ZN{cW6pIHXyRlIh\2WwZTD3bZRpKEmFNUCgc4YhOC53NDFOwG0> NInwfnAyQTZ4NUO3Oy=>
MCF7 MX NVP5cWdzTnWwY4Tpc44hSXO|YYm= Mnj0N|AhdWmw NVjsT|h3UW6qaXLpeIlwdiCxZjDCR3JRKGW6cILld5Nm\CC5aYToJGlEPTBib3[gNU4yKM7:TR?= NFLmPZUyQTl|Mkm2NC=>
A431 NHHsVlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX2xNEDPxE1? MkPOO|IhcA>? NYjTU45kT0l3ME2wMlUyPCEQvF2= M4DpcFE6QTZ7NE[1
A431 M4DmSGtqdmG|ZTDBd5NigQ>? NVz1VnJFOC5zIN88US=> NWPLXJl6OSCq NU\XVFJ3UW6qaXLpeIlwdiCxZjDFS2YucW6mdXPl[EBGT0[UIIDoc5NxcG:{eXzheIlwdg>? M3XzVFE6QTZ7NE[1
A431 MUjLbY5ie2ViQYPzZZk> M{TLdVExOCEQvF2= MojFNVAhdWmw MXzQdo9td26pZXSgbY5pcWKrdH;yfUBi[3Srdnn0fUBw\iCHR1[tbY5lfWOnZDDFS2ZTKHCqb4PwbI9zgWyjdHnvci=> NFfV[XMyQTl4OUS2OS=>
Sf9 MVvLbY5ie2ViQYPzZZk> MUCxNEBucW5? NX\nVGhJTE2VTx?= M4KxUGlvcGmkaYTpc44hd2ZiRVfGVkBmgHC{ZYPz[YQh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBz\WOncITvdkBifXSxcHjvd5Bpd3K7bHH0bY9vKHerdHigTWM2OCCxZjCwMlA{OyEQvF2= NIDEXXIzODB3NkSyOS=>
NCI-H1975 NYjTRnpiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEn0cpo2KM7:TR?= MlTHO|IhcA>? M1HTcWlEPTB;OD6yOkDPxE1? MkXrNlAyPTF4N{C=
NCI-H1975 NWjNWYJuU2mwYYPlJGF{e2G7 MkHBNVAh|ryP NV7ySmMyUW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25? M{jKflIxOTVzNkew
NCI-H1975 NFLXb2ZHfW6ldHnvckBCe3OjeR?= M2SwOVExKM7:TR?= MlTjTY5pcWKrdHnvckBw\iCHUlLCNkBifXSxcHjvd5Bpd3K7bHH0bY9v MoPTNlAyPTF4N{C=
NCI-H1975 NWHPfFBPTnWwY4Tpc44hSXO|YYm= NVvtS25EPSEQvF2= NX65TJZTPDhiaB?= NYnjO5F1UW6mdXP0bY9vKG:oIHHwc5B1d3OrczDhd5Nme3OnZDDhd{Bi[3SrdnH0bY9vKG:oIHPhd5Bie2VvMx?= MkiyNlAyPTF4N{C=
A375 NXXkOXV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{HVTVQ5KGh? NVLnbI1HUUN3ME2yNE42PSEQvF2= NWOxVHlJOjB|MES1N|c>
SMMC7721 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fRV|Q5KGh? NF\xXI5KSzVyPUOzMlEzKM7:TR?= MkDQNlA{ODR3M{e=
DU145 NG\5e|REgXSxdH;4bYMhSXO|YYm= MoH6OUBl NXS4fYxoTE2VTx?= M{jJe2lEPTB;NEKuNVch|ryP M1TabVIxPDZ4NUW1
MIAPaCa2 MoLZR5l1d3SxeHnjJGF{e2G7 NV75S3BWPSCm NYHGdFc4TE2VTx?= MWXJR|UxRTVyLk[yJO69VQ>? MYGyNFQ3PjV3NR?=
PANC1 MoW0R5l1d3SxeHnjJGF{e2G7 Mm[xOUBl MX3EUXNQ NEjTSoVKSzVyPUSwMlQzKM7:TR?= M3f4NlIxPDZ4NUW1
PC9 NGW4TFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1jPOWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgSWdHWi2mZX\pZ4lmdnRiaIXtZY4hWEN7IHPlcIx{KHerdHigSWM2OCCxZjCwMlAyPyEQvF2= NYXEfllFOjF{MEi4NFI>
PC9 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MljyRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDndo94fGhvcnXzbZN1[W62IHj1cYFvKFCFOTDj[YxteyCneIDy[ZN{cW6pIFXHSnIhTTd2Nm;BO|UxN1R5OUDNJI12fGGwdDD3bZRpKEWFNUCgc4YhPyEQvF2= M{XWc|IyOjB6OECy
PC3 NFqxTJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWmxNEDPxE1? MlWyO|IhcA>? M{\vfWROW09? MnnYTWM2OD15LkSg{txO MoLNNlE{PTN3NE[=
MDA-MB-468 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3HDRlExOCEQvF2= NH\mcFU1QCCq NEPIbIlFVVOR Mmr3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdIm= NUTJcGNVOjF2Mkm2N|I>
Plasmodium falciparum M2[x[JFJXFNicILv[oltcW6pIH\vdkBqdmirYnn0c5J{KG:oIGDsZZNud2SrdX2g[oFt[2myYYL1cUBxem:uaX\ldoF1cW:w Mlz4NlE5OTdyNEW=
NCI-H1993 NIXVXZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPTO|IhcA>? MXLEUXNQ NI\vWGJKSzVyPUCuNUDPxE1? Mli1NlE6OTZ2M{O=
NCI-H292 MkXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4XHVVczKGh? NWPN[GpnTE2VTx?= NEHQfGtKSzVyPUCuNFIh|ryP NH7BU2UzOTlzNkSzNy=>
A431 MYHLbY5ie2ViQYPzZZk> MlPmNkBp NVfiSIZ{TE2VTx?= MlSzTY5pcWKrdHnvckBw\iCHR1\SJJBpd3OyaH;yfYxifGmxbjDpckBGT0Zvc4TpcZVt[XSnZDDoeY1idiCDNEOxJJdqfGhiSVO1NEBw\iByLkCwNUDPxE1? NHfYUlkzOjFyMUGzNi=>
MCF7 M4m3NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1K0RVExOMLizsznM41N MVi0PEBp NF3pb2NFVVOR NXfS[GdPSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIh\2WwZTD3bZRpKEmFNUCgc4YhOTJwMEWg{txO NHHkWHkzOjFzOUGzNC=>
BT474 M{XOcGN6fG:2b4jpZ{BCe3OjeR?= NV\xUG1qOTBizszN NXzyVG1QPDhiaB?= NW[2RpNQS3m2b4TvfIlkcXS7IHHnZYlve3Ric3XyeY0ue3Sjco\l[EBpfW2jbjDCWFQ4PCClZXzsdy=> NWLMbFlkOjJzM{izNFg>
MCF7 NEjRdVhEgXSxdH;4bYMhSXO|YYm= M4nhdVExKM7:TR?= MYG0PEBp NGHke|NEgXSxdH;4bYNqfHliYXfhbY5{fCC|ZYL1cU1{fGG{dnXkJIh2dWGwIF3DSlch[2WubIOgc5Zmei2neIDy[ZN{cW6pIFXyZmIzKGOnbHzz NEWye4ozOjF|OEOwPC=>
HCC827 NEjjVpZMcW6jc3WgRZN{[Xl? MVmwMlEzPSEQvF2= NYHNVphlOjRiaB?= MknaSG1UVw>? NEezenlKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRiWUGwOlgh[XW2b4Doc5NxcG:{eXzheIlwdg>? M{nQc|IzOzN7M{Sy
HCC827 MXTLbY5ie2ViQYPzZZk> NFrlfnUxNjF{NTFOwG0> NV;sfnNiOjRiaB?= M3rNXGROW09? MoDETY5pcWKrdHnvckBw\iCHR1\SJIRmdCCHN{S2MWE4PTBibYX0ZY51NW2nZHnheIVlKEW{azDwbI9{eGixconsZZRqd25? NIXrUZQzOjN|OUO0Ni=>
HCC827 NHnRXnlMcW6jc3WgRZN{[Xl? M4XVR|AvOTJ3IN88US=> MmjTNlQhcA>? M4npcmROW09? NF;jc25KdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiQXv0JJBpd3OyaH;yfYxifGmxbh?= NEDDVIwzOjN|OUO0Ni=>
A431 NYTENGhHU2mwYYPlJGF{e2G7 NGHmU2UyODBizszN MmS5N|AhdWmw MlvOTY5pcWKrdHnvckBw\iCHR1\SJIRmemm4ZXSg[pJwdSCqdX3hckBCPDNzIHPlcIwhdWWvYoLhcoUh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBxd2y7LVfseU1VgXJicHjvd5Bpd3K7bHH0bY9vKHerdHigTWM2OCCxZjCxMlA5KM7:TR?= NFG4fpgzOjZ7OEe4Ni=>
H460 NH;UPJBEgXSxdH;4bYMhSXO|YYm= NV73XZFsPzJiaB?= NXnxVo5LUUN3ME21MlU6KM7:TR?= MX6yNlczPzR2OR?=
HT-29 MlfLR5l1d3SxeHnjJGF{e2G7 NU\kTJd6PzJiaB?= MlnjTWM2OD1|LkO2JO69VQ>? MYGyNlczPzR2OR?=
SGC7901 NITzWIpEgXSxdH;4bYMhSXO|YYm= MnnZO|IhcA>? NEnRfJpKSzVyPUGwMlI3KM7:TR?= NUHsZ|R3OjJ5Mke0OFk>
A498 NEjud4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF2OUigZ4VtdHNiZYjwdoV{e2mwZzDFS2ZTKGGwZDDTVmMhf2m2aDDJR|UxKG:oIEiuOkDPxE1? MXqyNlgyQDh2OB?=
Calu3 NWPTcG82S3m2b4TvfIlkKEG|c3H5 NVuyNmVqOTBizsznM41N MoHYO|IhcA>? MkflTWM2OD1zLk[g{txO MXOyN|EyPjF4OB?=
FADU MlK2R5l1d3SxeHnjJGF{e2G7 MYOxNEDPxGdxbVy= NFXF[|Y4OiCq M1yx[2lEPTB;MD6wOUDPxE1? MkTDNlMyOTZzNki=
HCC827 NEXFOJJEgXSxdH;4bYMhSXO|YYm= Mlz0NVAh|rypL33M NXm1ZoVzPzJiaB?= M3nLW2lEPTB;MD6wNFE2KM7:TR?= MojHNlMyOTZzNki=
PC9 MlrGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjGbotOOTBizsznM41N MV[3NkBp MorkTWM2OD1yLkCwNVQh|ryP MXOyN|EyPjF4OB?=
Sf9 MlHZT4lv[XOnIFHzd4F6 MUWxJIg> MX3EUXNQ MVHJcohq[mm2aX;uJI9nKGi3bXHuJGdUXC22YXfn[YQhTUeIUjDMPFM1WiCvdYThcpQh\XiycnXzd4VlKHerdHigTWM2OCCxZjCwMlAyPSEQvF2= NGrwfZEzOzZzMU[5NS=>
16HBE14o- M4LJXmN6fG:2b4jpZ{BCe3OjeR?= M{H3dVExKM7:TR?= MmrEO|IhcA>? NWrMRZhtTE2VTx?= M3qydWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJFE3UEKHMUTvMUBk\WyuczDoZZJjd3Krbnege4lt\CC2eYDlJGVITlJiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36ge4l1cCCLQ{WwJI9nKDF{LkexJO69VQ>? M3H4dFI{PjZ6NESx
NCI-H1975 NF;DcXBEgXSxdH;4bYMhSXO|YYm= NXPvRXNtOTBizszN M37FWlczKGh? NHfPS2VFVVOR M{jQNWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hVkOLLVixPVc2KGOnbHzzJIhiemKxcnnu[{BGT0[UIFy4OVhTN1R5OUDNJIRwfWKuZTDteZRidnRiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36ge4l1cCCLQ{WwJI9nKDZwOUG3JO69VQ>? MnvTNlM3Pjh2NEG=
16HBE MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUW3NkBp MV7EUXNQ M{PNfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iMU\IRmUh[2WubIOg[ZhxemW|c3nu[{B4cWymIIT5dIUhTUeIUjD3bZRpKEmFNUCgc4YhOS54MEGg{txO M4nxeFI{Pzl{M{G4
16HBE MVvGeY5kfGmxbjDBd5NigQ>? NF[xb|kyODBizszN Ml;xNVUxKG2rbh?= MoXGSG1UVw>? MYrJcoR2[3Srb36gc4Yhdmm2cnnjJI95cWSnIIDyc4R2[3Srb36gbY4hcHWvYX6gNVZJSkViY3XscJMh\XiycnXzd4lv\yC5aXzkJJR6eGViRVfGVi=> NYTvR4h6OjN5OUKzNVg>
A549 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4S0VFczKGh? M4XWR2ROW09? M1PuRmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4Sge4lt\CC2eYDlJGVITlJxaz3SZZMh\GWyZX7k[Y51KGi3bXHuJGE2PDliY3XscJMhf2m2aDDJR|UxKG:oIESuOlI3KM7:TR?= MkLTNlM4QTJ|MUi=
SH-SY5Y MlrvR5l1d3SxeHnjJGF{e2G7 MX:3NkBp MlPsTWM2OD1zOD6yNUDPxE1? MkLiNlM5PzF7MEm=
LoVo NXnsRoxqU2mwYYPlJGF{e2G7 NVG3cWlOOiBiaB?= NEHYdYZFVVOR MWXJcohq[mm2aX;uJI9nKEWJRmKgdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjB4MjFOwG0> M2r2PFI{QTNyOUm0
PC9 MYXLbY5ie2ViQYPzZZk> NV;TWI5IOiCq M3j6TWROW09? NVL0c2NXUW6qaXLpeIlwdiCxZjDFS2ZTKGW6b36gNVkh\GWuZYTpc44h[WO2aY\heIlv\yCvdYThcpQheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJHBEQSClZXzsd{B4cXSqIFnDOVAhd2ZiMD6wNFg4KM7:TR?= NEe5XmYzOzl|MEm5OC=>
HCC827 M3nsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7ROpFZPzJiaB?= MX\JR|UxRTBwMEGyJO69VQ>? NH3VTHQzOzl5M{G2PC=>
A549 NUDMUWNRU2mwYYPlJGF{e2G7 MVKxJO69VQ>? MVKxJIg> MnzWSG1UVw>? MmfkTY5pcWKrdHnvckBw\iCHR1\SJIF2fG:yaH;zdIhwenmuYYTpc44hf2m2aDDJR|UxKG:oIECuNFM6QSEQvF2= MmjyNlM6QDh|NUS=
A549 M{\PNWZ2dmO2aX;uJGF{e2G7 NIDNXHkyKM7:TR?= MUCxJIg> MoXKSG1UVw>? NGOyS5hE\WyudXzhdkB2eHSja3W= MUCyN|k5QDN3NB?=
HCC827 Ml;hT4lv[XOnIFHzd4F6 NVvGT3NYOC53IN88US=> MVWyJIg> NU\4Snl{TE2VTx?= M{HQUmlvcGmkaYTpc44hd2ZiRVfGVkBxcG:|cHjvdplt[XSrb36gbY4h\2WoaYTpcoljNXKnc3nzeIFvfCCqdX3hckBJS0N6MkegZ4VtdHN? Ml3BNlM6QTN|Mki=
HCC827 Mn3tSpVv[3Srb36gRZN{[Xl? NWHHUXo4OC53IN88US=> NUXae4xDOiCq MVXEUXNQ MlvaTY5pcWKrdHnvckBw\iClLV3leEBxcG:|cHjvdplt[XSrb36gbY4h\2WoaYTpcoljNXKnc3nzeIFvfCCqdX3hckBJS0N6MkegZ4VtdHN? NVzVeGFrOjN7OUOzNlg>
HCC827 M{jOUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjK[IYyOCEQvF2= NXnWd2xLPzJiaB?= NEnOPW9FVVOR MXrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHfl[ol1cW6rYj3z[Y5{cXSrdnWgbJVu[W5iSFPDPFI4KGOnbHzzJIhiemKxcnnu[{BGT0[UIFW3OFYhfG9iQUe1NEBl\WyndHnvckB4cXSqIFnDOVAhd2ZiMD6wNFU5OSEQvF2= MXWyOFA2OzZ5NB?=
A431 Mo\tT4lv[XOnIFHzd4F6 MnrNNVAxKM7:TR?= NHPEc5A{OCCvaX6= MoTXTY5pcWKrdHnvckBw\iCHR1\SJIlvKHOqZXSgcYVu[nKjbnWgeoV{cWOuZYOge4l1cCCLQ{WwJI9nKDFwMTFOwG0> M3TWWFI1ODl2NEOy
BCRP-MDCK2 M3fYbmZ2dmO2aX;uJGF{e2G7 MmT2NU45KM7:TR?= NUT0e5p6PzJiaB?= MlPTSG1UVw>? MYXJcoNz\WG|ZTDv[kBxdGG|bXGgcYVu[nKjbnWg[ZhxemW|c3nvckBw\iCEQ2LQJIV5eHKnc4PpcochemWyb4L0[ZIh\2WwZTDHSnA> M{K5WFI1OTh2MkGz
BCRP-MDCK2 NHK3WWhHfW6ldHnvckBCe3OjeR?= MWSxMlgh|ryP MYe3NkBp M3jXbGROW09? MVHS[YR2[3Srb36gc4YheGyjc33hJI1mdWK{YX7lJIV5eHKnc4Ppc44hd2ZiQlPSVEBmgHC{ZYPzbY5oKHKncH;yeIVzKGenbnWgS2ZR NF\PTWkzPDF6NEKxNy=>
MDCK NVT2OWtRS3m2b4TvfIlkKEG|c3H5 NV;1OGxiPzJiaB?= M2\Rd2ROW09? MXvHTVUxRTFwNEWg{txO MV6yOFE5PDJzMx?=
MDCK2 NGe1ZohHfW6ldHnvckBCe3OjeR?= NWfLNG1oOS56IN88US=> NEPYT3g4OiCq M2DXWmROW09? MXfJcohq[mm2aX;uJI9nKGi3bXHuJGJEWlBiZYjwdoV{e2WmIHHzd4V{e2WmIHHzJGhw\WOqc4SgN|M{PDJiYXPjeY12dGG2aX;uJJdqfGhiSVO1NEBw\iB|LkG5JO69VQ>? MWmyOFE5PDJzMx?=
A431 MUfDfZRwfG:6aXOgRZN{[Xl? MU[3NkBp NGfXSIlFVVOR NYDKS2x[S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTR|MTDj[YxteyCneIDy[ZN{cW6pIFXHSnIhf2m2aDDJR|UxKG:oIECuOVUh|ryP MnjyNlQ1OTFzMkO=
Calu3 NFnZbmhEgXSxdH;4bYMhSXO|YYm= MXK3NkBp MUfEUXNQ MXjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDZYx2OyClZXzsd{BmgHC{ZYPzbY5oKEiHUkKge4l1cCCLQ{WwJI9nKDBwOUmg{txO NWTrZnZHOjR2MUGxNlM>
KB NIG5[nRMcW6jc3WgRZN{[Xl? MUSxNEDPxE1? MXSxJIg> NWj2eI1QTE2VTx?= M336NGlvcGmkaYTpc44hd2ZiRVfGMZN1cW23bHH0[YQh[XW2b4Doc5NxcG:{eXzheIlwdiCxZjDFS2ZTKHerdHigTWM2OCCxZjCwMlAzPSEQvF2= MUCyOFQyOTF{Mx?=
BEAS2B NWfsWnNMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVTqVIYyPTBizszN NUXoeVE{PzJiaB?= MXvEUXNQ M3vS[2lEPTB;MUOuPVQh|ryP MkXpNlQ3ODd3OUG=
NCI-H1975 MWfGeY5kfGmxbjDBd5NigQ>? NUHKS|lrOTByIN88US=> NGLwV2YyPTBibXnu MojVSG1UVw>? MW\JcoR2[3Srb36gc4YhVk9icILv[JVkfGmxbjDpckBpfW2jbjDOR2kuUDF7N{WgZ4VtdHNiaHHyZo9zcW6pIFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51 NH3UcYgzPDZyN{W5NS=>
Hela NEfSSVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MViyOEBp NGGxR2tFVVOR MWnJR|UxRTJwNkeg{txO NXnjWm9{OjR5M{GyPFE>
HepG2 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnO1NlQhcA>? MXzEUXNQ MUHJR|UxRTZwNEKg{txO NXjvR3lMOjR5M{GyPFE>
Sf9 NI\NZXhMcW6jc3WgRZN{[Xl? NGnaXncyOCCvaX6= M4\RR2ROW09? MkXyTY5pcWKrdHnvckBw\iCjdYTvdIhwe3Cqb4L5cIF1cW:wIH;mJJJm[2:vYnnuZY51KGircz30ZYdo\WRiRVfGVkAp[W2rbn:gZYNq\CB4NEWtNVE5PiliZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjB{IN88US=> M3zvSFI1PzNzMkix
SW620 M17SZWN6fG:2b4jpZ{BCe3OjeR?= M1PDZ|Q5KGh? MULEUXNQ NYTxR2FIUUN3ME2yPE4zKM7:TR?= NEjFU3IzPDlyMEW5OC=>
HCC827 NXq2bIJoTnWwY4Tpc44hSXO|YYm= M4Xsc|AvPSEQvF2= NWD1bWQyOiCq NHzwZWZFVVOR M3XIUYRw\XNibn;0JIlvcGmkaYSgZ{1O\XRiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCDS2SgdIhwe3Cqb4L5cIF1cW:w NIfBWlAzOzl7M{OyPC=>
HCC827 M{nL[2Z2dmO2aX;uJGF{e2G7 MUmwMlUh|ryP MkHpNkBp M4LFSGROW09? M3LBO4Rw\XNibn;0JIlvcGmkaYSgZ{1O\XRiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCyNESvOFIheGixc4Doc5J6dGG2aX;u MlTaNlM6QTN|Mki=
HCC827 M3zmWGN6fG:2b4jpZ{BCe3OjeR?= MkjaNE42KM7:TR?= M4[0fFczKGh? MlrVSG1UVw>? NUfZbnNucGG|IH7vJIN6fG:2b4jpZ4l1gQ>? NV\SVW8xOjN7OUOzNlg>
NCI-H1975 NHTRfo9HfW6ldHnvckBCe3OjeR?= Mn7yNVAh|ryP NFvVWFk5KGh? M1XnWGROW09? NFHtSnFld2W|IH7veEBqdmirYnn0bUBGT0[UIHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCHUlugdIhwe3Cqb4L5cIF1cW:w M323eVI{OTF4MU[4
A431 MWPLbY5ie2ViQYPzZZk> NU\oVGg5OSEQvF2= NXPvdYZTOSCq MkDCSG1UVw>? M1nPZYhieyCwbzDpdpJmfmW{c3nicIUhcW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25? NH7HdYMzPDlyMEW5OC=>
LNCaP NYnlSXc{TnWwY4Tpc44hSXO|YYm= MVWxNEDPxE1? M2fjUFJpKG:{IESgbC=> NG\QWWdFVVOR NWHqfVZi\G:nczDuc5QhcW6qaXLpeEBifXSxcHjvd5Bpd3K7bHH0bY9vKG:oIHntcZVvd3C3cnnmbYVlKG[uYXeteIFo\2WmIFLtfEBie3Onc4Pl[EBieyCrbnPvdpBwemG2aX;uJI9nKFt|MmDdRXRR MYSxPFY3PzNzMh?=
H1975 MmG5T4lv[XOnIFHzd4F6 M1r4R|Eh|ryP MkCwNlQhcA>? MV3EUXNQ NEPWbVlld2W|IH7veEBqdmirYnn0JGVITlJicHjvd5Bpd3K7bHH0bY9vKGmwIHj1cYFvKEhzOUe1JINmdGy|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCPIH31eIFvfA>? NFr2OFYzPDZyN{W5NS=>
H1975 MYnGeY5kfGmxbjDBd5NigQ>? MYqxJO69VQ>? M1;XZlI1KGh? M{XHSGROW09? NVfqXIU{\G:nczDuc5QhcW6qaXLpeEBGWkticHjvd5Bpd3K7bHH0bY9vKGmwIHj1cYFvKEhzOUe1JINmdGy|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCP MYKyOFYxPzV7MR?=
HCC827 NFTsepZMcW6jc3WgRZN{[Xl? M3j5OVAvOTFizszN MoH2NUBp MYLEUXNQ NVXkc5RicGG|IH7vJIlzemW4ZYLzbYJt\SCrbnjpZol1cW:wIH;mJGVITlJiYYPz[ZN{\WRiYYOgdoVkd3[ncomgc4YhTUeIUjDheZRweGixc4Doc5J6dGG2aX;u MmrFNlQyOjR6OUi=
H1975 NID1W2JMcW6jc3WgRZN{[Xl? MnP1NE4{OyEQvF2= MYeyJIg> MV7EUXNQ M4LsN4Rw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBCU1RicHjvd5Bpd3K7bHH0bY9v MYOyOFEzPDh7OB?=
H1975 MUTLbY5ie2ViQYPzZZk> MWSwMlM{KM7:TR?= MVGyJIg> MVrEUXNQ NFjBS2dld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2g[I92[mynIH31eIFvfCCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hTVKNIIDoc5NxcG:{eXzheIlwdg>? MXSyOFEzPDh7OB?=
H1975 MVPLbY5ie2ViQYPzZZk> NXT1eGJuOC5|MzFOwG0> M2DZTFIhcA>? M{HFUWROW09? M2P4SoRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KHCqb4PwbI9zgWyjdHnvci=> MXmyOFEzPDh7OB?=
H1975 M2PlOWtqdmG|ZTDBd5NigQ>? NFHyTYgxNjF{NTFOwG0> MkH4NlQhcA>? MYjEUXNQ NU\sUpZi\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJI12fGGwdDDZNVA3QCCjdYTvdIhwe3Cqb4L5cIF1cW:w NXLnWVR4OjJ|M{mzOFI>
H1975 M4jZR2tqdmG|ZTDBd5NigQ>? M3TmW|AvPSEQvF2= MmXxNlQhcA>? M3T2PWROW09? M2PNe4Rw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?= MmTBNlI{Ozl|NEK=
H1975 M4Dkb2tqdmG|ZTDBd5NigQ>? NUTiNog4OC53IN88US=> M33iV|I1KGh? M2j5ZmROW09? NGexWWhld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62LX3l[IlifGWmIFHreEBxcG:|cHjvdplt[XSrb36= M3P2S|IzOzN7M{Sy
MIAPaCa2 M1;5O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\zNk42KM7:TR?= NHXJfog4OiCq M3nqR2ROW09? M3K1eIhieyCwbzDndo94fGhiaX7obYJqfGmxbh?= NF7GZmYzODR4NkW1OS=>
MIAPaCa2 MmS4R5l1d3SxeHnjJGF{e2G7 Mnr3NUDPxE1? MkXBNVAh\A>? MY\EUXNQ Mom5bIF{KG6xIHP5eI91d3irY3n0fUBie3Onc4Pl[EBieyC|dYDwdoV{e2mxbjDv[kBkd2yxbomg[o9zdWG2aX;u MnTYNlA1PjZ3NUW=
MIAPaCa2 NGPzNmVCeG:ydH;zbZMhSXO|YYm= Mlf4NVAh|ryP MYCyOIghd3JiNEigbC=> MlK3SG1UVw>? NUnaZ5M3\G:nczDuc5QhcW6mdXPlJIFxd3C2b4Ppdy=> MVyyNFQ3PjV3NR?=
MIAPaCa2 Mmr2RZBweHSxc3nzJGF{e2G7 NUjrOZBGOjBizszN M1LXWlI1KGh? MVXEUXNQ M2W0NIRw\XNibn;0JIlv\HWlZTDhdI9xfG:|aYOgZZN{\XO|ZXSgZZMh[2G|cHHz[UA{KGGldHn2ZZRqd25? NXHi[HJ7OjB2Nk[1OVU>
EoL-1 M4qzPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlHPTWM2OD13LkG3JI5O M2eyXXNCVkeHUh?=
NCI-H720 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnLETWM2OD1{Nj65NkBvVQ>? NWnrfIxsW0GQR1XS
NCI-SNU-5 NGL5RpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7U[odjUUN3ME2yPE4yQSCwTR?= NYjzW4dkW0GQR1XS
EW-3 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NES0fHdKSzVyPUS2MlA1KG6P NUnGSHVpW0GQR1XS
HCC2218 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTVyLkW5JI5O NVLNSmZuW0GQR1XS
HuO-3N1 NUj5bpFDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULsfYZ7UUN3ME21Ok4xQSCwTR?= MU\TRW5ITVJ?
DB M4H5XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILVWIRKSzVyPU[wMlk3KG6P NEPMfllUSU6JRWK=
HSC-4 M2exdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYj6fYttUUN3ME22NU42OyCwTR?= NUnT[YZ6W0GQR1XS
DOK NUPBOVNvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DISGlEPTB;OUOuOlIhdk1? NIj6WHZUSU6JRWK=
H9 NE\WXIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETqTHRKSzVyPUGzO{4zKG6P M2XS[XNCVkeHUh?=
NCI-H292 MnK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\kTWM2OD1zNkKuOlYhdk1? MYXTRW5ITVJ?
HSC-2 NVzrSJRYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmn4TWM2OD1zNkWuOVchdk1? MWnTRW5ITVJ?
LU-65 NWH3UW0zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTF4Nj62NUBvVQ>? NGni[YlUSU6JRWK=
BV-173 M2XxT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjFNY5KSzVyPUG4Ok42PSCwTR?= NXnwTZdUW0GQR1XS
LB2241-RCC NVnsSm1pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUXCWW1IUUN3ME2xPVQvQTNibl2= NFO3cFZUSU6JRWK=
KG-1 M13LSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnLCTWM2OD1{MESuN|Qhdk1? M4rPZnNCVkeHUh?=
CHL-1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vjb2lEPTB;MkC4MlUyKG6P MVPTRW5ITVJ?
KYSE-140 NWLCRnF5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmLYTWM2OD1{MEmuPVYhdk1? M{XuNHNCVkeHUh?=
DU-145 NYPvVlF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXLJR|UxRTJzOT6wOEBvVQ>? MYnTRW5ITVJ?
EW-13 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{DaNmlEPTB;MkK1MlEhdk1? NIOwZ5dUSU6JRWK=
KYSE-450 NV73e|Z2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmD3TWM2OD1{NEeuPVIhdk1? NHX3UmdUSU6JRWK=
CAL-72 NH2yUpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoL2TWM2OD1{NkiuO|Mhdk1? M4juXnNCVkeHUh?=
MEG-01 M3z5N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXnWXGZiUUN3ME2yO|YvPzZibl2= NITFbGxUSU6JRWK=
HCE-T NFPMR3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;3NldXUUN3ME2yO|kvPzlibl2= M2DMXHNCVkeHUh?=
NCI-SNU-1 NFLae3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3nQOmlEPTB;MkizMlMzKG6P MWnTRW5ITVJ?
CAL-27 M3vlW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTJ6OT6wPEBvVQ>? MYHTRW5ITVJ?
BALL-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTJ7Nz60NkBvVQ>? M2ThR3NCVkeHUh?=
SBC-1 NUfsXmUzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWTZcWZYUUN3ME2zNFcvPzlibl2= NIHQN5lUSU6JRWK=
CAL-54 M4Djfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPZTWM2OD1|MUGuNlMhdk1? NFTBSW9USU6JRWK=
TI-73 M1\jTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmHiTWM2OD1|MUKuO|Uhdk1? NX7MVGlbW0GQR1XS
P12-ICHIKAWA NWHQVIU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTN{OD6wOkBvVQ>? NXPxOY01W0GQR1XS
ACHN MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Moi3TWM2OD1|M{GuOEBvVQ>? NVjUUFRLW0GQR1XS
PC-14 NYS0[nJYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVXLcnJSUUN3ME2zN|MvPDFibl2= MWHTRW5ITVJ?
HCC1806 NFr0To1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3XSWlHUUN3ME2zN|cvPTFibl2= Moq2V2FPT0WU
SK-MEL-24 MmTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfGTWM2OD1|M{euPFchdk1? NX;ESWd5W0GQR1XS
A4-Fuk NVS4VGZZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGD6dFdKSzVyPUO1NE4xOiCwTR?= NVnMfFFPW0GQR1XS
ECC10 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEf5R5FKSzVyPUO1Nk46PiCwTR?= M376TnNCVkeHUh?=
KASUMI-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn;qTWM2OD1|Nk[uO|Mhdk1? NVPzcohvW0GQR1XS
CAL-33 NWf5TlhRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmO0TWM2OD1|N{CuPUBvVQ>? MorRV2FPT0WU
MDA-MB-175-VII MnXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTNTWM2OD1|N{iuPFghdk1? NXTQfmFuW0GQR1XS
NUGC-3 NW[zboU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnPsTWM2OD12MEGuPFEhdk1? NFroeIVUSU6JRWK=
KY821 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGHIbZdKSzVyPUSwPE42PyCwTR?= Mly2V2FPT0WU
CTB-1 MnTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2TzXWlEPTB;NEK0MlQhdk1? MXTTRW5ITVJ?
DoTc2-4510 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGfFb|dKSzVyPUS0Nk4yOiCwTR?= NGXaV2FUSU6JRWK=
EFO-27 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTR3ND63OEBvVQ>? MoTPV2FPT0WU
BPH-1 NVHUXll2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHrc3RKSzVyPUS5NU4yPiCwTR?= NUfUTWI1W0GQR1XS
KYSE-270 M3;0bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTR7OD62OUBvVQ>? MoHCV2FPT0WU
HO-1-N-1 NFHa[IdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYXsOY52UUN3ME21NFkvOjVibl2= MoryV2FPT0WU
SK-MEL-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV7kWJRqUUN3ME21NVAvQTlibl2= MWTTRW5ITVJ?
MOLT-13 M{fEfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXtTHJ3UUN3ME21NVQvQDJibl2= NHTF[5JUSU6JRWK=
TK10 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTVzNT6xNUBvVQ>? MWDTRW5ITVJ?
HN M3LvVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHPD[WpKSzVyPUWxO{4{QCCwTR?= MlLwV2FPT0WU
SCC-15 NF3hdXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWDjbpdrUUN3ME21NlUvPjhibl2= NHPRTZZUSU6JRWK=
NCI-H358 NFnyVZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn3XTWM2OD13MkeuOlYhdk1? NGTMS2JUSU6JRWK=
KYSE-180 M4exfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGnONFdKSzVyPUWzNE43OiCwTR?= MWrTRW5ITVJ?
NCI-H82 M2O5Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3\1VGlEPTB;NUSwMlUhdk1? M3TEWHNCVkeHUh?=
NB7 Ml;XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13FeWlEPTB;NUS2MlMzKG6P NX;CWW46W0GQR1XS
DSH1 NEWwNXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2Sz[2lEPTB;NU[2Mlg5KG6P M4P1c3NCVkeHUh?=
RS4-11 M2K0WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3zuR2lEPTB;NU[4MlU6KG6P MVrTRW5ITVJ?
CAN NXS2TXN4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MorQTWM2OD13OECuO|Yhdk1? NVTTOWtpW0GQR1XS
Ca9-22 MlfSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWrJR|UxRTV6OD62OEBvVQ>? NX:1VppDW0GQR1XS
CAL-39 NFfhZVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnyzTWM2OD13OU[uN{BvVQ>? NFjvd4pUSU6JRWK=
NCI-H1623 M3vEV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYrhZ5RzUUN3ME21PVkvOzZibl2= MXfTRW5ITVJ?
FADU M2X0Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7sTWM2OD14MESuOlkhdk1? MXvTRW5ITVJ?
NB69 M{fRWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUDkUVdnUUN3ME22NVQvOzVibl2= MWTTRW5ITVJ?
Ramos-2G6-4C10 MmDhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{PwcGlEPTB;NkKxMlQ3KG6P NGTUdI5USU6JRWK=
LB1047-RCC MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWrJfYdnUUN3ME22NlUvOjlibl2= NVznTHo3W0GQR1XS
MV-4-11 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1mxfGlEPTB;NkK3Mlchdk1? Mk\IV2FPT0WU
DBTRG-05MG MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTCTWM2OD14M{KuNlghdk1? Ml;EV2FPT0WU
ME-180 MknqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUPJR|UxRTZ|Mj65JI5O NVuwcXF2W0GQR1XS
NBsusSR NE\mb|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn;oTWM2OD14NE[uOVIhdk1? M3\2SXNCVkeHUh?=
COR-L105 M{TUR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3zTWM2OD14NkKuOVMhdk1? Mm\rV2FPT0WU
ETK-1 NV24ZmdDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1v3XWlEPTB;Nk[yMlU6KG6P MXLTRW5ITVJ?
L-363 NV\nOXZjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn33TWM2OD14N{GuPVQhdk1? MnHNV2FPT0WU
LU-134-A NUGyXGl{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mny4TWM2OD15MUmuNFkhdk1? NGrrN4hUSU6JRWK=
NCI-H1770 MlnsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH;p[YFKSzVyPUeyNk41KG6P Mli5V2FPT0WU
HAL-01 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUC5V4hGUUN3ME23N|QvPzFibl2= NWHIe5hKW0GQR1XS
COLO-684 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHmVnNKUUN3ME23OVMvODFibl2= NFvSRmlUSU6JRWK=
TE-6 MoHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{PZR2lEPTB;N{[0MlMyKG6P Mof6V2FPT0WU
A431 M2PKOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYmyS|Z5UUN3ME23PFAvODRibl2= MoDJV2FPT0WU
LU-135 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV;VUFBXUUN3ME23PFMvODNibl2= MojiV2FPT0WU
EC-GI-10 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV22OYp2UUN3ME23PFgvPTJibl2= NV7YXGkzW0GQR1XS
TE-12 NFXCenlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGqzTXlKSzVyPUiyNU4yOSCwTR?= MkDWV2FPT0WU
LoVo M1rGfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWnJV2RbUUN3ME24OVkvODZibl2= NFO5Vo1USU6JRWK=
23132-87 NIC0VYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TEUGlEPTB;OE[0MlI5KG6P Mn3CV2FPT0WU
AU565 NVHaSVBnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnvWTWM2OD16NkmuOkBvVQ>? NGrK[YZUSU6JRWK=
DEL M{T1PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHXIfllKSzVyPUi3O{43PSCwTR?= NEnJSYJUSU6JRWK=
COR-L88 M1PXdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnXTWM2OD16OEKuNlYhdk1? M1H3VnNCVkeHUh?=
NCI-H2126 M1LYc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV6zOHM5UUN3ME24PFIvQDNibl2= M2i0bHNCVkeHUh?=
CAPAN-1 NUO1TJM1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mor4TWM2OD16OEOuNlkhdk1? MnTRV2FPT0WU
BT-474 MnriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGn4TVJKSzVyPUmzPE4yPCCwTR?= MV\TRW5ITVJ?
BHY M1[3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoDtTWM2OD17N{WuOFghdk1? MlHZV2FPT0WU
HT-3 NXfCT2d7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUixb3RZUUN3ME25PFIvPDFibl2= MWTTRW5ITVJ?
SK-NEP-1 M3XXO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVLJR|UxRTl6OT60OEBvVQ>? MYXTRW5ITVJ?
MS-1 M1jkUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF2zU5lKSzVyPUm5OE43QSCwTR?= M4\TeXNCVkeHUh?=
DOHH-2 NVfiTnY4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XGSGlEPTB;MT6wNFAzOSEQvF2= M3\sZXNCVkeHUh?=
NCI-H1304 MoKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWTJR|UxRTFwMEG2OFMh|ryP MWnTRW5ITVJ?
EM-2 MoLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXXJR|UxRTFwMEOwNVYh|ryP NV:3UId4W0GQR1XS
MHH-PREB-1 NXryWVZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3zUGdoUUN3ME2xMlA5PDVzIN88US=> M3m4bnNCVkeHUh?=
KU-19-19 NGXUSGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnLhTWM2OD1zLkC4OVQyKM7:TR?= Ml36V2FPT0WU
NCI-H1648 MlTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHXzZ25KSzVyPUGuNVA3OTZizszN MXXTRW5ITVJ?
MKN1 MnvqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUGzSnRFUUN3ME2xMlIyQTh5IN88US=> NXrvdGtVW0GQR1XS
SNU-449 NEfyS4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fmNmlEPTB;MT6yNlIxQCEQvF2= Mn72V2FPT0WU
OAW-42 MlvrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFLielFKSzVyPUGuNlc5OjVizszN NGqxTVRUSU6JRWK=
769-P MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmT1TWM2OD1zLkK3PVE5KM7:TR?= MXXTRW5ITVJ?
SW1088 NV;PW4VHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfvd2pKSzVyPUGuNlk3ODdizszN MYfTRW5ITVJ?
GCIY NIDW[JVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7ZTWM2OD1zLkOwNVMzKM7:TR?= MmTBV2FPT0WU
CTV-1 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnPYTWM2OD1zLkOwPEDPxE1? MkPvV2FPT0WU
NCI-H1092 Mm\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLQR5dKUUN3ME2xMlMxQDVizszN NU\1eFltW0GQR1XS
NKM-1 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\icYpMUUN3ME2xMlMzPTl5IN88US=> M1[2XHNCVkeHUh?=
NCI-H1650 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzPXGhKSzVyPUGuN|M1QDJizszN MX7TRW5ITVJ?
SW954 NFfZfWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTFwM{SwOFgh|ryP MlfnV2FPT0WU
SW48 NI\rVGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHjNIFKSzVyPUGuN|Y3OThizszN M370TXNCVkeHUh?=
SK-N-DZ MkTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{\YbmlEPTB;MT6zOlk1PyEQvF2= MWnTRW5ITVJ?
KMOE-2 M1jnPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWfRZlltUUN3ME2xMlM6QDF3IN88US=> NHjm[4FUSU6JRWK=
NB5 MlTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX3JR|UxRTFwNEC4PVQh|ryP Mle4V2FPT0WU
CCRF-CEM MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnrQTWM2OD1zLkSxNVEh|ryP MUPTRW5ITVJ?
RH-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFzZVplKSzVyPUGuOFEyOzZizszN NGXJRY9USU6JRWK=
NCI-H526 NH[wbY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY\yVnRzUUN3ME2xMlQ{QDJ4IN88US=> NFWzclNUSU6JRWK=
697 M17JPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTFwNESxNFQh|ryP MU\TRW5ITVJ?
J82 NGHxXI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2\ybGlEPTB;MT60OVc3PiEQvF2= NUjtNoxbW0GQR1XS
BE-13 NU\U[|B3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXnSfYs5UUN3ME2xMlUxPjdzIN88US=> MVLTRW5ITVJ?
SAS NF:yb3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGjrb3ZKSzVyPUGuOVE3OjJizszN M37HbnNCVkeHUh?=
SCC-25 NUeyZ|k{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTFwNUKzNlIh|ryP MUDTRW5ITVJ?
LAMA-84 NH7RS2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTFwNUO4NVUh|ryP NH3BRoVUSU6JRWK=
HSC-3 NW\MfJc{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPUN|BKSzVyPUGuOVQ{QCEQvF2= NXL1WWFDW0GQR1XS
BT-549 NV;HT3JOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkXkTWM2OD1zLkW4O|Q4KM7:TR?= MVzTRW5ITVJ?
ML-2 MnnsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTKTWM2OD1zLk[0NFI6KM7:TR?= M13afnNCVkeHUh?=
BB30-HNC MkD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHjUe5ZKSzVyPUGuOlg6PzJizszN M3v0bXNCVkeHUh?=
PANC-03-27 NIq5NVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHvWe25KSzVyPUGuO|AyOzlizszN MUfTRW5ITVJ?
COLO-678 MnXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2fDemlEPTB;MT63N|Q1PCEQvF2= NEexZVRUSU6JRWK=
NCI-H1666 M4TXPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLmTWM2OD1zLke0O|A1KM7:TR?= MWHTRW5ITVJ?
NCI-H209 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIKxVW9KSzVyPUGuO|czPjlizszN NIWwTGRUSU6JRWK=
EPLC-272H NHq3SGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3X3WGlEPTB;MT64OVU1QSEQvF2= M{Xjb3NCVkeHUh?=
OMC-1 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\lWotKSzVyPUGuPVk5QDhizszN M{HDVHNCVkeHUh?=
HCC70 M2[2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1\zcGlEPTB;Mj6wNFgyPSEQvF2= M{\lSXNCVkeHUh?=
CAL-12T MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NULzfJRrUUN3ME2yMlAyQDZzIN88US=> NULuR2dUW0GQR1XS
TGBC24TKB NVHyeVNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYjmcG9lUUN3ME2yMlAzQTZzIN88US=> NFnTTIFUSU6JRWK=
EKVX M1T5U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV:1XVlsUUN3ME2yMlA1QTN7IN88US=> NGnKU4pUSU6JRWK=
SW1116 NHjp[3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fRb2lEPTB;Mj6wOlAxQSEQvF2= NV\QOItbW0GQR1XS
NCI-H2009 MnjQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLCTWM2OD1{LkC2NlE1KM7:TR?= NVK5WWp{W0GQR1XS
RPMI-8866 MnTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnwVoo2UUN3ME2yMlA5PDhzIN88US=> NX62NVk6W0GQR1XS
KARPAS-45 NIfvZnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTJwMUK0O|kh|ryP MkPJV2FPT0WU
RXF393 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPmZXlKSzVyPUKuNVMxOzZizszN MXrTRW5ITVJ?
786-0 M{OxOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInUS3ZKSzVyPUKuNVg1ODZizszN MnTvV2FPT0WU
SCC-4 NIPj[WxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETSWHNKSzVyPUKuNlE4PzZizszN NGroRXdUSU6JRWK=
BT-20 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEPVXFFKSzVyPUKuNlY4PDRizszN MkHIV2FPT0WU
A498 M{LYTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV25OGlEUUN3ME2yMlI6PDF3IN88US=> MlHWV2FPT0WU
IGROV-1 NY\2[3hyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33sW2lEPTB;Mj6zNVI{PyEQvF2= M1fj[XNCVkeHUh?=
JVM-3 NIDMOm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3WRWQ1UUN3ME2yMlM1PjR|IN88US=> MUPTRW5ITVJ?
NCI-H2170 M3\re2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjXWVNKSzVyPUKuN|Q4QDNizszN MoXQV2FPT0WU
EW-18 NUjZV2RQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\U[2lEPTB;Mj6zOVQ4OSEQvF2= M36yUnNCVkeHUh?=
KU812 MnfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHPb2xKSzVyPUKuN|Y4PzlizszN NHPFOVlUSU6JRWK=
NY M1Ly[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILNNHJKSzVyPUKuN|czPyEQvF2= Mk\NV2FPT0WU
HTC-C3 M3WzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrCfJo2UUN3ME2yMlQzOjZ5IN88US=> Mo\TV2FPT0WU
CFPAC-1 NHXZd5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYXXTGdRUUN3ME2yMlQ{QDZ2IN88US=> NVuw[GJ1W0GQR1XS
HH NYnGO2o5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXOTWM2OD1{LkS5PFU1KM7:TR?= NXjaO3JkW0GQR1XS
MKN7 MnO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NITNbnFKSzVyPUKuOlI4PDhizszN Mmf6V2FPT0WU
TE-8 NETZTGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYrJR|UxRTJwNkO2OVMh|ryP NHzTe|lUSU6JRWK=
MC-IXC MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXq0TWhDUUN3ME2yMlY1PDV|IN88US=> Mnz6V2FPT0WU
DMS-79 NH:yTJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXrQWJJXUUN3ME2yMlY6Ojh2IN88US=> M2fEfHNCVkeHUh?=
Detroit562 NHjNZY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTJwNkm4OFUh|ryP NIPCUG5USU6JRWK=
HuP-T4 MkTQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnvXTWM2OD1{LkeyPFE5KM7:TR?= NH3qVmhUSU6JRWK=
QIMR-WIL MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7jSIRKSzVyPUKuO|U6PTJizszN MWTTRW5ITVJ?
BB65-RCC MmXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGSyUVFKSzVyPUKuPFA4OTNizszN M2nE[XNCVkeHUh?=
PC-3 NIfPXWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MofuTWM2OD1{LkizN|E4KM7:TR?= NXj1W5ZTW0GQR1XS
OVCAR-3 M{jNb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mkj3TWM2OD1{Lki1OVk1KM7:TR?= NVLnNnRVW0GQR1XS
KYSE-510 NVjQcWtuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MU\JR|UxRTJwOE[3PFYh|ryP MlX1V2FPT0WU
HC-1 NV3OU|EyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULENWhOUUN3ME2yMlk1ODF{IN88US=> MmjsV2FPT0WU
NCI-H1693 M4rRNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3kPGdRUUN3ME2yMlk2QDl5IN88US=> NV64O412W0GQR1XS
DU-4475 M3jMNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml\oTWM2OD1{Lkm5NFUzKM7:TR?= NHnyNXVUSU6JRWK=
COLO-680N M3fWb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRTNwMEC0PVUh|ryP M3T5SHNCVkeHUh?=
MN-60 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVnJR|UxRTNwMES5O|Qh|ryP NGXw[pNUSU6JRWK=
BCPAP NH23VlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HkdGlEPTB;Mz6wPFI6PSEQvF2= MUnTRW5ITVJ?
647-V MoSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;UbGtKSzVyPUOuNVYzOiEQvF2= MV7TRW5ITVJ?
HT-1376 NXjDSlJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXiyfpgyUUN3ME2zMlIxPTB4IN88US=> M3XzbHNCVkeHUh?=
NCI-H1793 MojOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnrhTWM2OD1|LkKxNFk5KM7:TR?= MYHTRW5ITVJ?
SW1463 NFzmc21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoDUTWM2OD1|LkK2NVkzKM7:TR?= NWq5NnliW0GQR1XS
NCI-H727 MmPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXPnfHdxUUN3ME2zMlM5PTh2IN88US=> M134THNCVkeHUh?=
LB771-HNC MmDRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTNwM{mxNlYh|ryP MnnxV2FPT0WU
D-542MG MlLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTNwNESyNlIh|ryP NEDMcIJUSU6JRWK=
NTERA-S-cl-D1 NULPWVIzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLMTWM2OD1|LkS0PVU4KM7:TR?= M1\2V3NCVkeHUh?=
C8166 M3W4fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfK[Y9[UUN3ME2zMlQ3PTJzIN88US=> MlfMV2FPT0WU
639-V NWS1S3VvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVn0eXVGUUN3ME2zMlU4Pzl{IN88US=> M2PHbXNCVkeHUh?=
TE-1 NWn1bW5LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVzJR|UxRTNwNUmxOlkh|ryP MXfTRW5ITVJ?
OAW-28 NV3wU2RrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXToNnFnUUN3ME2zMlU6PDJ4IN88US=> NVj6UYs2W0GQR1XS
SK-LU-1 M1e4e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3BOFVKSzVyPUOuOlA3PDVizszN MnjpV2FPT0WU
CaR-1 M4LG[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1m0SmlEPTB;Mz62NVA1QCEQvF2= MkfvV2FPT0WU
A2780 Mn3GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTNwNkSwPFkh|ryP NGC1SYpUSU6JRWK=
C2BBe1 Mor3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NI\yS3dKSzVyPUOuOlQ1ODdizszN M1;5NHNCVkeHUh?=
SK-MES-1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHPoZ5ZKSzVyPUOuOlQ3OTRizszN MkXYV2FPT0WU
PANC-10-05 M2XDU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH30bnpKSzVyPUOuO|IxPzJizszN MmTXV2FPT0WU
J-RT3-T3-5 MnHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYDJR|UxRTNwN{W0NFYh|ryP NGr0bWRUSU6JRWK=
ES4 M4jzWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\5bINKSzVyPUOuPFIzQDZizszN MYXTRW5ITVJ?
NCI-H28 NFXD[HFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3XzVWlEPTB;Mz64Nlk3OSEQvF2= NFi4OGhUSU6JRWK=
NCI-H1155 MnrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEHVSW9KSzVyPUOuPFQyPTlizszN NWHidmNpW0GQR1XS
KURAMOCHI MlS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjPWJNKSzVyPUOuPFYxPTZizszN MkTSV2FPT0WU
NCI-H69 M{\tZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVjJR|UxRTNwOUCxO|gh|ryP M165NnNCVkeHUh?=
IST-MES1 M1\QWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3rOmtKSzVyPUOuPVQxOjlizszN M1XkT3NCVkeHUh?=
NH-12 MmTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnzGTWM2OD1|Lkm0NVg4KM7:TR?= MoCwV2FPT0WU
JVM-2 M2nuNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIi1[IFKSzVyPUOuPVQ4PTJizszN NFHyUodUSU6JRWK=
EW-16 M3[5Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PVOmlEPTB;Mz65OVU4PyEQvF2= NFXrVIJUSU6JRWK=
NCI-H441 NV[xcW9OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVqwU2p5UUN3ME2zMlk4ODF2IN88US=> NH23WXJUSU6JRWK=
RCC10RGB NVK5SYhmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnOcFg6UUN3ME20MlAyOjR4IN88US=> MlfTV2FPT0WU
TCCSUP M{\QN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;BUJpKSzVyPUSuNVExPSEQvF2= M{LYRnNCVkeHUh?=
HL-60 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPLTWM2OD12LkGyNlQyKM7:TR?= MYDTRW5ITVJ?
EW-11 M{TiR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFfVV4hKSzVyPUSuNVMzPjFizszN MV;TRW5ITVJ?
KARPAS-299 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnzUTWM2OD12LkOxNFE{KM7:TR?= M2rTNXNCVkeHUh?=
SNU-C2B M4nhZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3XMO2lEPTB;ND6zOFY5PiEQvF2= M1LXfnNCVkeHUh?=
LU-139 Mkj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTRwM{eyOFch|ryP M1LrdnNCVkeHUh?=
HCC1937 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfBOW12UUN3ME20MlM4QTl|IN88US=> M1fsV3NCVkeHUh?=
GR-ST NVfEcGdNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYHJR|UxRTRwNEOxPEDPxE1? MoDHV2FPT0WU
SK-OV-3 NWHhcJExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MonFTWM2OD12LkS2NFQzKM7:TR?= NFvrelFUSU6JRWK=
A172 NF;yTpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIjK[GpKSzVyPUSuOVU2OjFizszN Ml\jV2FPT0WU
NB10 NFT4SJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnHjTWM2OD12LkW5O|gyKM7:TR?= NX:xOHNrW0GQR1XS
P30-OHK MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LnNWlEPTB;ND64NVkzQSEQvF2= M3jpPXNCVkeHUh?=
KYSE-520 NGPBfVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{PtdmlEPTB;ND64PFAyQCEQvF2= MX7TRW5ITVJ?
KNS-62 NX[wWIc3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUTpNJZUUUN3ME20MlkxQDB5IN88US=> NIPFZnVUSU6JRWK=
ES1 MnfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVHDcoZzUUN3ME20Mlk3ODN3IN88US=> NHLSU3ZUSU6JRWK=
KOSC-2 MorNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HSVmlEPTB;ND65PVk2QSEQvF2= NV2y[lh[W0GQR1XS
TE-9 NHPvTnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmnCTWM2OD13LkCxOVI2KM7:TR?= NGLGdHlUSU6JRWK=
NCI-H1838 NFPT[phIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M363SWlEPTB;NT6wNlA4PiEQvF2= M{LIT3NCVkeHUh?=
KP-N-YN MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4ThfGlEPTB;NT6xNlU6OSEQvF2= NFLXSZpUSU6JRWK=
ALL-PO NXfaPGg{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn:xTWM2OD13LkKyOVg4KM7:TR?= NXnUeoRNW0GQR1XS
NOMO-1 NFzDUIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGX5[oxKSzVyPUWuNlMyPzZizszN M{LSPXNCVkeHUh?=
CGTH-W-1 NE\FRpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTVwM{i1PFQh|ryP MnjNV2FPT0WU
ATN-1 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTVwNEGxPFQh|ryP MVvTRW5ITVJ?
AGS NV3qUld6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoHKTWM2OD13LkS5OlE5KM7:TR?= M2qzZ3NCVkeHUh?=
SW13 MnTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\EfmlEPTB;NT61N|I3PSEQvF2= M3z1dnNCVkeHUh?=
SW1990 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;BXGlEPTB;NT62NlI5PSEQvF2= NWnqcJlDW0GQR1XS
BFTC-905 M1LNZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFXDd49KSzVyPUWuOlU5PzhizszN M2n3fnNCVkeHUh?=
RMG-I M4GzNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnLXTWM2OD13Lk[1PVQzKM7:TR?= NIHheZVUSU6JRWK=
HD-MY-Z Ml;xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWGyT2ZrUUN3ME21MlY5PThzIN88US=> NFvBWm5USU6JRWK=
HCC1187 M1PL[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HxS2lEPTB;NT63NVA{OiEQvF2= NWHhcZJsW0GQR1XS
HCC2998 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnzpTWM2OD13LkexPFc4KM7:TR?= NHLnTYpUSU6JRWK=
RT-112 M1;VeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTVwOUCyOFUh|ryP NHfj[mtUSU6JRWK=
CAKI-1 Mm\QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkLXTWM2OD14LkCwPVg2KM7:TR?= MmTWV2FPT0WU
HDLM-2 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4jmSWlEPTB;Nj6wNVQ5QSEQvF2= MXnTRW5ITVJ?
TE-10 MnfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrtTWM2OD14LkC0PFM{KM7:TR?= M1vwdnNCVkeHUh?=
KE-37 NHTSeIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRTZwMEeyOVgh|ryP Mn;SV2FPT0WU
RCM-1 MkTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;pTWM2OD14LkC3O|E6KM7:TR?= NEDWdFRUSU6JRWK=
Mewo M2rS[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH;MdXdKSzVyPU[uNVE1QDdizszN MWLTRW5ITVJ?
L-428 M4LGV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTZwMUiwN|ch|ryP NHPaS3FUSU6JRWK=
8-MG-BA MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF6zT3pKSzVyPU[uNVk{PzlizszN M2jHNXNCVkeHUh?=
SK-MEL-28 M4jNemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXITWM2OD14LkKwPVY4KM7:TR?= NXvkPZFlW0GQR1XS
VA-ES-BJ NEDl[3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1Xrc2lEPTB;Nj6zNFQ3OiEQvF2= MonzV2FPT0WU
CAL-120 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVPEeY1PUUN3ME22MlQ2OTZ{IN88US=> NIe2[I5USU6JRWK=
GAMG NVHo[4NQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTZwNUC2NkDPxE1? NU\LPHg6W0GQR1XS
MSTO-221H NEHGflBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{m3eWlEPTB;Nj61NVE4KM7:TR?= MnnPV2FPT0WU
GCT NEnoXlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFfaSYdKSzVyPU[uOVM{QDdizszN Mm\LV2FPT0WU
SH-4 MmftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\uUYN1UUN3ME22MlU5QDR2IN88US=> NYTZTYljW0GQR1XS
Calu-3 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzETWM2OD14Lk[1OVY5KM7:TR?= NXT0b|NFW0GQR1XS
SK-HEP-1 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHMTWM2OD14LkexO|U{KM7:TR?= NYPJOVZ4W0GQR1XS
PFSK-1 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1fPO2lEPTB;Nj63N|Q4QCEQvF2= NEHDRoxUSU6JRWK=
NB12 NEHPZ|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MojuTWM2OD14Lke4OFA1KM7:TR?= MWjTRW5ITVJ?
A388 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTwOpMxUUN3ME22Mlg6PTJizszN NW\BOVQ1W0GQR1XS
KLE MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mke2TWM2OD14Lkm2OVE3KM7:TR?= NIfxWXlUSU6JRWK=
TE-11 NVjoNXBMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnP2TWM2OD15LkC0PVY4KM7:TR?= NXnRUJRJW0GQR1XS
NCI-H2405 M{XWVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\ldnNKSzVyPUeuNFg{QTNizszN M1\ocnNCVkeHUh?=
OVCAR-4 NEftUWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mmn3TWM2OD15LkG1N|Uh|ryP MWnTRW5ITVJ?
KP-N-YS MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfLdnBbUUN3ME23MlE5OTRizszN NY[5TmlzW0GQR1XS
NOS-1 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYnJR|UxRTdwMkW4Nlgh|ryP NY[1cXBTW0GQR1XS
DMS-114 MlyzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTdwMkm2N|Eh|ryP M{nJc3NCVkeHUh?=
NCI-H2030 M{\CZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnHLTWM2OD15LkOzOlk5KM7:TR?= NHfh[YpUSU6JRWK=
HEL M37tNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH7lcoZKSzVyPUeuN|c2OjFizszN M{HOS3NCVkeHUh?=
CAL-62 NVP3c|BwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUjJR|UxRTdwM{m4OlYh|ryP NG\2SXhUSU6JRWK=
COLO-668 M2LSNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkDrTWM2OD15LkSzPVY4KM7:TR?= M1zyfHNCVkeHUh?=
SKG-IIIa NXTtOFdHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTdwNEWzPFEh|ryP M3vZ[HNCVkeHUh?=
HCC1419 NILsWINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHPLT5ZKSzVyPUeuOFY5OzNizszN MlLSV2FPT0WU
OS-RC-2 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYG0WHlMUUN3ME23MlQ6QDl2IN88US=> NG\UcpdUSU6JRWK=
COLO-829 Mnv5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTdwNk[0OlMh|ryP NH\RSVRUSU6JRWK=
NB13 NGfU[pFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2HQbWlEPTB;Nz64NlY3PyEQvF2= MnnmV2FPT0WU
DK-MG M2nPOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYjUWnliUUN3ME23Mlg{OjBzIN88US=> NFyyPJlUSU6JRWK=
SHP-77 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nmbGlEPTB;Nz64OlY2OyEQvF2= NWXuUJBmW0GQR1XS
NCI-H661 M2nYTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVG1blZWUUN3ME24MlA2QDZ5IN88US=> M17KNXNCVkeHUh?=
AM-38 NX3BUVN1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULPTFBoUUN3ME24MlE3OjhizszN NETJe5RUSU6JRWK=
VM-CUB-1 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRThwMUewNlkh|ryP Ml33V2FPT0WU
KYSE-70 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUHJR|UxRThwMUm3OlEh|ryP NVPvclYzW0GQR1XS
5637 NXnW[2JLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRThwM{GwOVUh|ryP NH7ndGVUSU6JRWK=
TGBC11TKB M{P5TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRThwNE[xOlQh|ryP NFrycnlUSU6JRWK=
EGI-1 M{PQXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkWwTWM2OD16Lk[wNFg5KM7:TR?= NIjqUodUSU6JRWK=
D-392MG NF63NYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHq5d3BKSzVyPUiuOlYzOTRizszN MYTTRW5ITVJ?
A673 NH;6[ohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;jfnp4UUN3ME24MlY4PjFzIN88US=> M4nsPHNCVkeHUh?=
COLO-792 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXXdmhKSzVyPUiuO|Q6PDZizszN NFr4UFRUSU6JRWK=
NCI-H1792 M1LkOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmHiTWM2OD16Lki4PVA{KM7:TR?= NHzqVmpUSU6JRWK=
LS-1034 M{DJWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3hUmJKSzVyPUiuPVQ3PTJizszN NX\OOWI3W0GQR1XS
D-566MG MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkjvTWM2OD17LkCxPFEh|ryP NVfMSFFUW0GQR1XS
NCI-H226 M3fVSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWGxS2RDUUN3ME25MlA6KM7:TR?= NVfuNFNqW0GQR1XS
ChaGo-K-1 NYm0cFRtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoPKTWM2OD17LkGwOVc6KM7:TR?= NF\iN3RUSU6JRWK=
NCI-H2228 M{fTOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{fCUGlEPTB;OT6xNVA5OSEQvF2= NXLJU25mW0GQR1XS
RPMI-8226 NF7EcZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3rCWmlEPTB;OT6xNVMxPCEQvF2= M{TJdHNCVkeHUh?=
BFTC-909 NFjkN4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTlwMUiyPVch|ryP M1Hj[XNCVkeHUh?=
HPAF-II NFe3ZlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTlwMkK1NVgh|ryP M1OwOXNCVkeHUh?=
Capan-2 M1r0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYHRUpNSUUN3ME25MlQxOTB7IN88US=> M2q0PXNCVkeHUh?=
IA-LM MoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTlwNEG5OlYh|ryP NHjJZnNUSU6JRWK=
KP-4 NITRfWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTlwNEi4N|gh|ryP NUj2S|Z1W0GQR1XS
A101D MmTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTlwNUG3NVkh|ryP M3W0V3NCVkeHUh?=
EFO-21 NYfofYc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFvudWhKSzVyPUmuOVg4OzVizszN M3[2W3NCVkeHUh?=
C32 NUHLfmhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYC5eZUyUUN3ME25MlY{OzRizszN M2fRPXNCVkeHUh?=
SW837 NIHFSWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXrJR|UxRTlwOES4NkDPxE1? NYrGUoRoW0GQR1XS
OCI-AML2 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3X6UmlEPTB;OT64Olk3KM7:TR?= MnzVV2FPT0WU
NCI-H1355 M{DKPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTlwOUSwPFgh|ryP M4rNW3NCVkeHUh?=
NCI-H2342 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTFyLkCxOVUh|ryP NWXVWpVsW0GQR1XS
A204 M1rjXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF\UbXRKSzVyPUGwMlA1PjZizszN NYHiXWR3W0GQR1XS
CAL-51 NF;sbmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTJZVJHUUN3ME2xNE4xQDd5IN88US=> MlfQV2FPT0WU
HCE-4 NWezPZZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;PTWM2OD1zMD6xNVIzKM7:TR?= M4DCeXNCVkeHUh?=
NCI-H810 MoPIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn3TTWM2OD1zMD6xOVk4KM7:TR?= M1XyOnNCVkeHUh?=
DJM-1 MnnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTFyLkG3N|Ih|ryP NHHFeldUSU6JRWK=
SK-UT-1 NITjem5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;Ud2hlUUN3ME2xNE4zPTd2IN88US=> MmTUV2FPT0WU
U031 NGroUGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH7ZZ5dKSzVyPUGwMlI3QDZizszN NWTDW|RnW0GQR1XS
YH-13 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NULCT|lrUUN3ME2xNE4{ODV5IN88US=> NVj4SYc6W0GQR1XS
K5 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILZfYZKSzVyPUGwMlM{QTVizszN M3[zTnNCVkeHUh?=
HEC-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2ruW2lEPTB;MUCuOFA5OSEQvF2= NGr4cXhUSU6JRWK=
A2058 NIPPT2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfGRmtKSzVyPUGwMlU1QTFizszN MVfTRW5ITVJ?
SW962 M1;QW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fQfWlEPTB;MUCuOlIxPCEQvF2= MUPTRW5ITVJ?
VMRC-RCZ MmjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1fE[mlEPTB;MUCuOlc1QSEQvF2= MXPTRW5ITVJ?
D-336MG NEDIVWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTFyLkewNFUh|ryP NIfpUnpUSU6JRWK=
LXF-289 Mn7wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3v0bmlEPTB;MUCuO|k3PyEQvF2= NVn5[o1vW0GQR1XS
SW900 M{X5W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmnlTWM2OD1zMD64NlI5KM7:TR?= MUTTRW5ITVJ?
K-562 NVeyZ|FrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTFyLkizPVUh|ryP NXXmdWZZW0GQR1XS
HCC38 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWX5elhiUUN3ME2xNE46PzF4IN88US=> NIm1UlFUSU6JRWK=
SF-295 NF3ZfVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4LSZmlEPTB;MUCuPVkxOiEQvF2= Mn75V2FPT0WU
LB831-BLC M3zrT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFL3OJBKSzVyPUGxMlI2PTZizszN NFnESmJUSU6JRWK=
FTC-133 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFj0UIRKSzVyPUGxMlMxQDFizszN NGTLNmZUSU6JRWK=
HCC1954 NWLsWnFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NW\VUGJ6UUN3ME2xNU41OzZizszN NXLIV4t[W0GQR1XS
GOTO NXOyNmJjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHTaNY1KSzVyPUGxMlUzODZizszN NWHub|dTW0GQR1XS
LS-411N M{L2[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37kS2lEPTB;MUGuOlExOSEQvF2= MXLTRW5ITVJ?
RPMI-7951 M{TaPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkLtTWM2OD1zMT62N|Q5KM7:TR?= MnuxV2FPT0WU
NCI-H1299 M3L2XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkPLTWM2OD1zMT62OlQ4KM7:TR?= NYrJR3VWW0GQR1XS
MLMA NGnK[4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LTOWlEPTB;MUGuOlk6PyEQvF2= M1y3bXNCVkeHUh?=
MMAC-SF NHnNUXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4Dlb2lEPTB;MUGuO|I2OiEQvF2= NFWweGNUSU6JRWK=
UM-UC-3 M17lTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTFzLke0NlEh|ryP M3vzRXNCVkeHUh?=
SCC-9 MlHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUntbppTUUN3ME2xNU45OTVzIN88US=> NH;0c|dUSU6JRWK=
HOS MoftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\2e3VGUUN3ME2xNU45Pjh|IN88US=> MVzTRW5ITVJ?
OE19 M1n1N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1vs[2lEPTB;MUGuPVM3PyEQvF2= MnWzV2FPT0WU
Mo-T NEf6Xo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXfuT5hxUUN3ME2xNU46PTRzIN88US=> NHvQW3RUSU6JRWK=
CAMA-1 MoTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXLwVG5IUUN3ME2xNk4yPjN|IN88US=> MXLTRW5ITVJ?
U-118-MG NIi4fHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TneGlEPTB;MUKuNlQ1OSEQvF2= Mn7hV2FPT0WU
KS-1 NHX0OphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MonzTWM2OD1zMj6yPFMzKM7:TR?= MoLrV2FPT0WU
JAR NWnjWIZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mlm4TWM2OD1zMj6zN|Y6KM7:TR?= MUjTRW5ITVJ?
ABC-1 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NInnZm1KSzVyPUGyMlM1OSEQvF2= M4O3SHNCVkeHUh?=
Daoy NHPxfJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmGzTWM2OD1zMj60OVQzKM7:TR?= MXrTRW5ITVJ?
C3A NVPCTlE4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYLTb5dDUUN3ME2xNk42Pzh3IN88US=> NGOzcFhUSU6JRWK=
GT3TKB MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnMWXBVUUN3ME2xNk43OzJ5IN88US=> MV;TRW5ITVJ?
DMS-273 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVPJR|UxRTF{Lki2N|Mh|ryP NXvTZWNvW0GQR1XS
G-361 NH73R|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFLKbYxKSzVyPUGyMlkyOjlizszN MUTTRW5ITVJ?
RH-18 NFLNOFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTF|LkK5OlIh|ryP Mnq2V2FPT0WU
SN12C MmrkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzOZYF{UUN3ME2xN{4{QDB6IN88US=> Ml[1V2FPT0WU
NCI-H1993 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MU\JR|UxRTF|LkSyPFUh|ryP NEX4VGVUSU6JRWK=
LOXIMVI MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{LGNGlEPTB;MUOuOlE2OSEQvF2= MnnIV2FPT0WU
SK-PN-DW NYrZSYVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHTSZnlKSzVyPUGzMlg1OjdizszN NU\sWZY2W0GQR1XS
KALS-1 NVLjc2dDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml7JTWM2OD1zMz64OVI2KM7:TR?= Mn7hV2FPT0WU
LAN-6 NV\HeYZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTF2LkK1N{DPxE1? NFL0dm9USU6JRWK=
A549 NIm0WIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXrybmZ2UUN3ME2xOE41PzF{IN88US=> NI\pOmZUSU6JRWK=
RD M{Tj[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmDTTWM2OD1zND60PFE{KM7:TR?= NVrqT41TW0GQR1XS
TGBC1TKB NYHQNo5YT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MornTWM2OD1zND62OlE2KM7:TR?= NIj1c4JUSU6JRWK=
NCI-H630 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVTJR|UxRTF2Lkm0Olch|ryP NELlcFhUSU6JRWK=
MIA-PaCa-2 MnXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFiySW9KSzVyPUG0Mlk3QSEQvF2= M2XmPHNCVkeHUh?=
NCI-H1755 NXSwZop5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGC5XIJKSzVyPUG0Mlk6PTNizszN MUjTRW5ITVJ?
MOLT-4 NWD5NW1ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTF3LkC0PVch|ryP NWmyRllLW0GQR1XS
CW-2 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDTTWM2OD1zNT6xOFIyKM7:TR?= NXLZbJlpW0GQR1XS
COLO-320-HSR NGfSWIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnrOTWM2OD1zNT61N|A4KM7:TR?= MXPTRW5ITVJ?
UMC-11 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3HSb2lEPTB;MUWuO|UzOyEQvF2= NGfvOpFUSU6JRWK=
MCF7 NYLtN4JGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIrDTGVKSzVyPUG1MlgyPDVizszN NG\jfXlUSU6JRWK=
NCI-H23 MkHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2flU2lEPTB;MUWuPFQ{QCEQvF2= NEjNXolUSU6JRWK=
HuCCT1 M336SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH6zRZZKSzVyPUG1Mlg4PCEQvF2= MkHZV2FPT0WU
MPP-89 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\Be2dKSzVyPUG1Mlk1OTdizszN NITs[GhUSU6JRWK=
HT55 M{fDeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXfCcZdlUUN3ME2xOU46PDd6IN88US=> NGntR3RUSU6JRWK=
no-11 M3[wZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3nwWGlEPTB;MUWuPVY3OyEQvF2= MVTTRW5ITVJ?
GP5d MlLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXXJR|UxRTF4LkKxPFch|ryP M4LSZXNCVkeHUh?=
BHT-101 MnnXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;OWoJKSzVyPUG2MlI1OzlizszN NWXETWRuW0GQR1XS
M059J MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{HER2lEPTB;MU[uNlg1KM7:TR?= MUjTRW5ITVJ?
D-283MED MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUH5[5RXUUN3ME2xOk41OjB7IN88US=> NUDSfXFUW0GQR1XS
BEN NIjtcm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFXjbYhKSzVyPUG2MlUyPTVizszN NEPGUIZUSU6JRWK=
LB373-MEL-D NF3hVZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTF4LkeyN|Ih|ryP MkTvV2FPT0WU
MEL-HO MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3GW3pKSzVyPUG2Mlg5PTRizszN M4XrV3NCVkeHUh?=
GI-ME-N NHvFW3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoG4TWM2OD1zNj65NFMzKM7:TR?= Mlj4V2FPT0WU
RKO NVGx[oxyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYrJR|UxRTF5LkC3OFgh|ryP NWDQV5VPW0GQR1XS
MZ2-MEL M4HCVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml\ITWM2OD1zNz6xN|Mh|ryP MUXTRW5ITVJ?
NCI-H1573 M2fUNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTF5LkK4NlYh|ryP NHrKT4FUSU6JRWK=
NCI-H1581 NHjEco1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFS1ZWFKSzVyPUG3MlQ1OTFizszN MmjsV2FPT0WU
NCI-H747 M2XnNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHTTNXdKSzVyPUG3MlUzQTdizszN NEfHSYRUSU6JRWK=
SW1783 NVK5NI57T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYDJR|UxRTF5Lk[0NVUh|ryP MmrhV2FPT0WU
Calu-6 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFL2ZlVKSzVyPUG3MlY4QDJizszN MkLVV2FPT0WU
SF268 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYnJR|UxRTF5Lk[5Olkh|ryP NUS3b3BCW0GQR1XS
ES8 MlHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XPXmlEPTB;MUeuPFU6OyEQvF2= MoHIV2FPT0WU
KM-H2 MnPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzJSWd4UUN3ME2xO{46PDFzIN88US=> NIH4THBUSU6JRWK=
D-502MG M121UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\jN5BRUUN3ME2xO{46QDB6IN88US=> MmTUV2FPT0WU
HLE NUPUPG81T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzOTWM2OD1zOD6zNVQ5KM7:TR?= NIrORWRUSU6JRWK=
SW982 M3zp[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MofOTWM2OD1zOD60NFc2KM7:TR?= NYfiW4o2W0GQR1XS
MDA-MB-361 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITZN3hKSzVyPUG4MlU2QDhizszN NXjsRY91W0GQR1XS
NCI-H1563 NFjsTGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTF6LkexNlQh|ryP MYXTRW5ITVJ?
MFE-280 NFHJTItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEDBXVhKSzVyPUG4MlczQTNizszN MUfTRW5ITVJ?
U251 MorZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LKemlEPTB;MUiuO|M1PyEQvF2= NVnWeo8zW0GQR1XS
KNS-42 NU\xT5RZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYe1U3l4UUN3ME2xPE45ODF3IN88US=> M2XT[3NCVkeHUh?=
U-266 M3zzcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYjJR|UxRTF6Lki2OFkh|ryP M{nEXXNCVkeHUh?=
OVCAR-8 MnLwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTF6LkmyO|Yh|ryP MoXoV2FPT0WU
MFH-ino NYH3SIFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnH3TWM2OD1zOD65OlY6KM7:TR?= NIDobYdUSU6JRWK=
D-263MG M4r0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4XZfmlEPTB;MUmuNFE4OiEQvF2= M3;hfXNCVkeHUh?=
NCI-H1437 NFfOS3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHs[nhDUUN3ME2xPU4xPDZ5IN88US=> Ml3oV2FPT0WU
NCI-H1048 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnfHTWM2OD1zOT6yN|I3KM7:TR?= MlzGV2FPT0WU
NCI-H446 NXLLUI9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIewbJRKSzVyPUG5MlM2QDlizszN MVrTRW5ITVJ?
NCI-N87 MlPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1vJ[GlEPTB;MUmuOVk6OiEQvF2= NUi4bmlwW0GQR1XS
WM-115 M1LTOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnHwTWM2OD1zOT62O|c1KM7:TR?= NVTuR|UxW0GQR1XS
HuH-7 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTF7Lke0NlEh|ryP Mn;kV2FPT0WU
NCI-H650 NUKwTJoxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn63TWM2OD1zOT63OVA5KM7:TR?= NXnzSGtQW0GQR1XS
TYK-nu NFmwbWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUPJR|UxRTF7LkizO|gh|ryP MXnTRW5ITVJ?
Becker NFi3Z4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljaTWM2OD1zOT64OVQ4KM7:TR?= NHXT[2RUSU6JRWK=
BB49-HNC MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHmXIFKSzVyPUG5MlkzKM7:TR?= NEnMe5NUSU6JRWK=
HGC-27 Mn3QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmPWTWM2OD1{MD6xN|k1KM7:TR?= NXzFOXBuW0GQR1XS
SiHa MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{HYb2lEPTB;MkCuN|cyOiEQvF2= MYDTRW5ITVJ?
LB2518-MEL MmLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HR[GlEPTB;MkCuN|c{QSEQvF2= MlzaV2FPT0WU
TE-5 Mm\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDhR5BKSzVyPUKwMlc1QDJizszN M3TJe3NCVkeHUh?=
IST-SL1 M2\DWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHPaZ5JKSzVyPUKwMlc5PzlizszN NF\HUW9USU6JRWK=
A375 NVHEdG1ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\HUGlEPTB;MkGuNFU3PyEQvF2= MX3TRW5ITVJ?
MC116 MnzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTJW|h7UUN3ME2yNU4xPzJ|IN88US=> NHfSWppUSU6JRWK=
GI-1 MljRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nWNmlEPTB;MkGuNVch|ryP Mn6yV2FPT0WU
HOP-62 NIDISJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rW[WlEPTB;MkGuNlc5PCEQvF2= MkHMV2FPT0WU
PA-1 NEOycJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPpcmxKSzVyPUKxMlI4QDdizszN Mkn4V2FPT0WU
HT MnjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\zVW56UUN3ME2yNU41OzNzIN88US=> MVnTRW5ITVJ?
HUTU-80 NHjDcJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVzJR|UxRTJzLkSzN|Yh|ryP Mn;wV2FPT0WU
NCI-H1975 NW[yVJRtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mm\vTWM2OD1{MT60OlEh|ryP NHnKZpdUSU6JRWK=
GAK MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;NWWlEPTB;MkGuOFk6KM7:TR?= NFTxOFFUSU6JRWK=
SK-N-AS NI\1R5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XUWGlEPTB;MkGuOVYyQSEQvF2= M4PCXnNCVkeHUh?=
OE33 MkTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmfwTWM2OD1{MT62NFQ3KM7:TR?= NIC3UXFUSU6JRWK=
YKG-1 MlL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXnJR|UxRTJzLk[1OFUh|ryP MW\TRW5ITVJ?
CAL-85 NY\PbXE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXXb4JKSzVyPUKxMlk{ODVizszN M4\DdHNCVkeHUh?=
NCI-H2347 NVfo[Zd2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MofUTWM2OD1{MT65OFI5KM7:TR?= MWXTRW5ITVJ?
PANC-08-13 MluxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPUN2RKSzVyPUKyMlAyOTlizszN NUHCRoJHW0GQR1XS
SK-N-FI NYq3[phrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHHbmdpUUN3ME2yNk4{ODd2IN88US=> NUTZVlhsW0GQR1XS
NEC8 M{\CZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTJ{LkWwO|gh|ryP MUTTRW5ITVJ?
AN3-CA MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2HIUmlEPTB;MkKuOlA5PCEQvF2= NYjhe3hKW0GQR1XS
HuO9 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV3JR|UxRTJ{LkezPVYh|ryP MX7TRW5ITVJ?
COLO-800 NX7lcGZWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTJ{Lke2OVMh|ryP NXj6RlZNW0GQR1XS
HT-29 M1vycmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTJ{Lki4NlMh|ryP NU\vT4hNW0GQR1XS
OC-314 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGm0c|JKSzVyPUKyMlg5PDVizszN MnH4V2FPT0WU
G-401 MlLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jRS2lEPTB;MkOuNFQ3OiEQvF2= NV7INJBsW0GQR1XS
Saos-2 Mn\5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlTYTWM2OD1{Mz61NVgzKM7:TR?= MX7TRW5ITVJ?
UACC-62 M3;wemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3oTWM2OD1{Mz61PFM{KM7:TR?= NF75Oo5USU6JRWK=
D-247MG NHTlTGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTJ|Lke5N|kh|ryP NIK4dVlUSU6JRWK=
COLO-741 NVf0TXdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPhOJRKSzVyPUKzMlk2PjVizszN NWS1UFBHW0GQR1XS
ES3 NWe0Uox{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTJ2LkCwNlMh|ryP M{Hjb3NCVkeHUh?=
LNCaP-Clone-FGC MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4faXmlEPTB;MkSuNFIyOSEQvF2= M4\TfnNCVkeHUh?=
SW1710 MkO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXrJR|UxRTJ2LkG1NFYh|ryP NXjFe3YzW0GQR1XS
LU-99A M2j3NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1K3U2lEPTB;MkSuNVg1OSEQvF2= MUXTRW5ITVJ?
HOP-92 M4ixVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXrvNI1wUUN3ME2yOE44OjVizszN M1\zXXNCVkeHUh?=
LS-123 M1e3VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jXO2lEPTB;MkSuPVYyPCEQvF2= NWfEd2F[W0GQR1XS
T84 NITwNphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYrsSINiUUN3ME2yOE46PzZ3IN88US=> M{OwSXNCVkeHUh?=
HCT-116 M1T3b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1LDb2lEPTB;MkWuOFE5PiEQvF2= MkPxV2FPT0WU
M14 M3vrbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3zv[mlEPTB;MkWuOFQ1PyEQvF2= MoqzV2FPT0WU
OCUB-M MoLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFvxU49KSzVyPUK1MlQ1PTZizszN MU\TRW5ITVJ?
MKN45 NGjqOlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XXR2lEPTB;MkWuOlMyPSEQvF2= NIjyVpVUSU6JRWK=
LCLC-97TM1 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mo\yTWM2OD1{NT63Nlg2KM7:TR?= M1GzSHNCVkeHUh?=
RVH-421 NVvoRYdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTJ3LkixOlEh|ryP NYi4OJVGW0GQR1XS
NKS-81-FD MmnOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFq2TGxKSzVyPUK1MlkxOjFizszN NWTKTndrW0GQR1XS
NCI-H596 MoPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml7qTWM2OD1{Nj6wOFg4KM7:TR?= MXnTRW5ITVJ?
GB-1 M3n6U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYHHfI9nUUN3ME2yOk4yQDd7IN88US=> NYTielR4W0GQR1XS
ZR-75-30 NEnMSXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M17wOGlEPTB;Mk[uNlI6PyEQvF2= MlHvV2FPT0WU
U-2-OS M1XET2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUfDdHNsUUN3ME2yOk4{PzV5IN88US=> NVXtdo9vW0GQR1XS
HuP-T3 NIT3TlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXnFTo9TUUN3ME2yOk43OTB{IN88US=> NWrwT25sW0GQR1XS
MOLT-16 NF7PPFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmrOTWM2OD1{Nj62NVY3KM7:TR?= NFXrdHRUSU6JRWK=
U-87-MG MlTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrXTWM2OD1{Nj63OFM5KM7:TR?= NIjsUW5USU6JRWK=
8505C M3ewc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYTJR|UxRTJ4LkmxNlYh|ryP M17OUXNCVkeHUh?=
SK-MEL-3 Mke3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3GxN2lEPTB;Mk[uPVgzQCEQvF2= MWnTRW5ITVJ?
COLO-824 M2T5b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVT2TVc1UUN3ME2yO{4zOTl3IN88US=> MUnTRW5ITVJ?
EW-1 NYroTIRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYrMUW9QUUN3ME2yO{4{PTV2IN88US=> Mmq2V2FPT0WU
UACC-257 NITQWYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPPdZEzUUN3ME2yO{4{QDB2IN88US=> Mlm0V2FPT0WU
Hs-578-T M4DBc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH7ORYRKSzVyPUK3MlUzQTlizszN NHXDVopUSU6JRWK=
UACC-893 MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF74NFRKSzVyPUK3MlY3OzFizszN MVjTRW5ITVJ?
MHH-NB-11 NY\4UooxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLlTWM2OD1{Nz64NFA4KM7:TR?= NHm2SJFUSU6JRWK=
KYSE-410 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NInHcIVKSzVyPUK4MlI4PzlizszN M3GxWnNCVkeHUh?=
SF126 M1mzUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWLjcmc3UUN3ME2yPE44PDN3IN88US=> NVeyUIZXW0GQR1XS
HT-144 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHS4XYRKSzVyPUK5MlM{PjJizszN M{PZ[3NCVkeHUh?=
SW1573 MofBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUe0c3NrUUN3ME2yPU4{PTB7IN88US=> MXfTRW5ITVJ?
SW620 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGO5XopKSzVyPUK5MlM3PDFizszN M{eydXNCVkeHUh?=
SCH MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYPJR|UxRTJ7Lki4N|Eh|ryP M3m4XnNCVkeHUh?=
EW-22 NYnyfnl4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlHTTWM2OD1|MD6xPVY6KM7:TR?= MnO0V2FPT0WU
H4 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnXXolKSzVyPUOwMlQ3PTRizszN M3PsV3NCVkeHUh?=
CAS-1 M1G2WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTNyLke4OVkh|ryP M{DpSnNCVkeHUh?=
MG-63 NFTXfIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnBTWM2OD1|MD64OFc5KM7:TR?= MWDTRW5ITVJ?
MDA-MB-415 NYHtdG1lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRTNzLkG3OVMh|ryP NHHFVHRUSU6JRWK=
NCI-H1395 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTNzLkKzNlgh|ryP NUfybWxDW0GQR1XS
Ca-Ski NYrqR3ZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;WTWM2OD1|MT6zNVc4KM7:TR?= M4\vcXNCVkeHUh?=
BxPC-3 NHPadHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{GyUGlEPTB;M{GuN|czQSEQvF2= NFzXWGxUSU6JRWK=
A3-KAW MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzaRZpKSzVyPUOxMlQ1PzFizszN NFG3PWVUSU6JRWK=
T-24 NInYXWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4L6N2lEPTB;M{GuO|M3OiEQvF2= NHTMRWFUSU6JRWK=
NCI-H2029 NWT2TmZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TxWWlEPTB;M{GuO|c3PSEQvF2= M4HVVXNCVkeHUh?=
YAPC NHPRTYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTN{LkC0NFch|ryP M1XlNHNCVkeHUh?=
SK-MEL-2 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTN{LkC1NkDPxE1? NYq1fpJvW0GQR1XS
LS-513 MmHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTN{LkGxPFch|ryP MYHTRW5ITVJ?
AsPC-1 NFPpVYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHCU5VKSzVyPUOyMlM3ODVizszN NYXVbItIW0GQR1XS
KYSE-150 MnS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTN{LkO3O|Mh|ryP M{LLSHNCVkeHUh?=
NCI-H520 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvKN2Q1UUN3ME2zNk41PDh{IN88US=> M2G5XHNCVkeHUh?=
JEG-3 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1rISWlEPTB;M{OuNFk4OSEQvF2= M{nJfHNCVkeHUh?=
GMS-10 NHLSVYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXiTWM2OD1|Mz6zNFA1KM7:TR?= NVXxWYo2W0GQR1XS
HT-1080 NHvYVVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NELndolKSzVyPUOzMlM6KM7:TR?= MWjTRW5ITVJ?
NCI-H1651 M3S5W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDWfnpKSzVyPUOzMlM6PiEQvF2= MomzV2FPT0WU
NCI-H2122 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPyTWM2OD1|Mz61OVc1KM7:TR?= M3\KO3NCVkeHUh?=
ES5 NV;JbnNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUjFcVhOUUN3ME2zN{44Ojl{IN88US=> MnfnV2FPT0WU
8305C NGfiNpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7YZZVLUUN3ME2zN{46QTN5IN88US=> MXvTRW5ITVJ?
KM12 MlTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHkZZlKSzVyPUO0MlA1PzhizszN NH;uVXJUSU6JRWK=
HCT-15 NWPFUWc1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPmWVlXUUN3ME2zOE4yOjdizszN NYLDbmRXW0GQR1XS
OVCAR-5 M3TmbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojSTWM2OD1|ND6yNVgzKM7:TR?= MmD6V2FPT0WU
NCI-H2291 NG\5VZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmnhTWM2OD1|ND6yOFczKM7:TR?= MkHmV2FPT0WU
CP50-MEL-B M2npcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTYSJdDUUN3ME2zOE43PTl{IN88US=> NYfQ[WJ2W0GQR1XS
C-33-A NXPuSodLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIP4cXZKSzVyPUO0MlY5PTdizszN NUn4VnVQW0GQR1XS
NCI-H2452 MkmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnUXo1KSzVyPUO0Mlc5QDJizszN M4fKOXNCVkeHUh?=
MDA-MB-157 NGnmcoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYDZTJBqUUN3ME2zOE45OTl|IN88US=> MXLTRW5ITVJ?
LN-405 MoDsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkTHTWM2OD1|NT60N|A5KM7:TR?= M1;KUnNCVkeHUh?=
MDA-MB-231 M2P5cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTWTWM2OD1|NT61NFU1KM7:TR?= M{C1VXNCVkeHUh?=
EW-24 NInSb4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUfJR|UxRTN3Lk[zN|Uh|ryP MYHTRW5ITVJ?
MKN28 NIWwRnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTN3LkiyN|Yh|ryP NG\wTpNUSU6JRWK=
KINGS-1 Mn\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETEboNKSzVyPUO1Mlg1OzRizszN M{fsOXNCVkeHUh?=
LC-2-ad NEjz[IVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRTN4Lk[5PUDPxE1? NVe0cI5OW0GQR1XS
IGR-1 M4\Sbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV[5e2FqUUN3ME2zOk44ODd3IN88US=> M2fOZXNCVkeHUh?=
SW626 NYrNVG93T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmi1TWM2OD1|Nz6wOFE4KM7:TR?= MUfTRW5ITVJ?
ONS-76 NXrPT2Q5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYPkXZpGUUN3ME2zO{4yOzB7IN88US=> NX3UUWhOW0GQR1XS
T98G MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWPHRYp[UUN3ME2zO{45PjN3IN88US=> NYW5dmtkW0GQR1XS
NB14 M2HaXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTN6LkS1OFQh|ryP MWnTRW5ITVJ?
D-423MG M2L3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTkTWM2OD1|OD60PFY6KM7:TR?= M3[2RnNCVkeHUh?=
NCI-H510A Mn7uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4L2bmlEPTB;M{iuOlQ2OSEQvF2= MXnTRW5ITVJ?
NMC-G1 M3XYTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTN6LkeyNlIh|ryP NHrIcHFUSU6JRWK=
SW948 Mnz2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTN6Lki5OFkh|ryP NYS3fFZyW0GQR1XS
MFM-223 Mn76S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWjIVm9NUUN3ME2zPE46PDNzIN88US=> M2DwVHNCVkeHUh?=
PAN1 NWi2U4ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVHJR|UxRTN6Lkm5NVkh|ryP Mm\NV2FPT0WU
MZ7-mel M{TFPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGKzS|BKSzVyPUO5MlEyQTlizszN M1rPPHNCVkeHUh?=
COLO-679 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXnt[ndbUUN3ME2zPU46PzB6IN88US=> NIezXWVUSU6JRWK=
SW872 NHmyUnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnL3TWM2OD12MD6yNFMyKM7:TR?= M2rMPHNCVkeHUh?=
HT-1197 M1rkRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfJ[mtCUUN3ME20NE4zQDZ7IN88US=> MYfTRW5ITVJ?
ES6 Mo\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXXNFFGUUN3ME20NE41PTV{IN88US=> Mk\YV2FPT0WU
SNU-387 NWjMNJlyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVvESlhsUUN3ME20NE45OjN6IN88US=> NG\TenJUSU6JRWK=
T47D MnHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPPe2JKSzVyPUSxMlAyQTJizszN M1\YZ3NCVkeHUh?=
G-402 M3npdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MofITWM2OD12MT6wPFA6KM7:TR?= MnHJV2FPT0WU
MZ1-PC MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILJXm1KSzVyPUSxMlgyKM7:TR?= MlTEV2FPT0WU
SW1417 NXix[XJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHme|VlUUN3ME20Nk4{ODNizszN NH3MV3BUSU6JRWK=
RERF-LC-MS NH\kcm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVjTRlU{UUN3ME20Nk42ODh5IN88US=> M2jE[XNCVkeHUh?=
SF539 M4nNN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTR{LkW1Nlkh|ryP M{LPTHNCVkeHUh?=
ESS-1 M1PNOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXaXpR7UUN3ME20N{42PTV6IN88US=> NEXu[|FUSU6JRWK=
RO82-W-1 Mn;vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTR|Lk[xOVMh|ryP M4X5R3NCVkeHUh?=
S-117 M2XzVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH61bZRKSzVyPUSzMlY6PThizszN MmThV2FPT0WU
SW756 M{PJR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkiwTWM2OD12Mz64NlQzKM7:TR?= MVvTRW5ITVJ?
CP66-MEL MnvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1W4fGlEPTB;NEWuO|E1OyEQvF2= M{TORXNCVkeHUh?=
H-EMC-SS MkixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUPp[4s{UUN3ME20OU44Pjl|IN88US=> NGHnSppUSU6JRWK=
NCI-H2052 NEnRR5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvLdJF[UUN3ME20OU46ODJ5IN88US=> NX3pNWpVW0GQR1XS
SW684 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFrJWGhKSzVyPUS3MlAxQDFizszN MX7TRW5ITVJ?
HCC1569 M2XONWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFPSOFNKSzVyPUS3MlE3PThizszN NVTBNHdyW0GQR1XS
KGN NYXrNI1JT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{i0dWlEPTB;NEeuN|MyOSEQvF2= M2fXU3NCVkeHUh?=
LCLC-103H M4TSPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTR5LkS0NFQh|ryP NUnQUm1oW0GQR1XS
SW780 MkXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTR5Lk[zOVEh|ryP M3jreXNCVkeHUh?=
NCI-H1703 M1LNWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnLVTWM2OD12OD6zN|UzKM7:TR?= NGSzSoFUSU6JRWK=
HCC1395 NXG1fWNNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGrJTHFKSzVyPUS4Mlc1OzJizszN NYfiU3hHW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Gefitinib (100 mg/kg) improves the anti-tumor effect of radiotherapy in LoVo tumor xenografts. [3] Gefitinib treatment of nude mice bearing established human GEO colon cancer xenografts reveals a reversible dose-dependent inhibition of tumor growth because GEO tumors resumes the growth rate of controls at the end of the treatment. [4]

Protocol

Cell Research:[1]
+ Expand
  • Cell lines: NR6, NR6M and NR6W cells
  • Concentrations: 0-2 μM
  • Incubation Time: 72 hours
  • Method: Exponentially growing cells including NR6, NR6M, NR6M and NR6W cells are seeded in sextuple in 96-well plates at a concentration of 2000 cells/well, allowed to adhere and subsequently washed in PBS and incubated overnight in medium containing 0.5% FCS. Cells are then treated with varying concentrations (0-2 μM) of Gefitinib or the solute control DMSO and EGF. The optimal EGF concentration for inducing proliferation of NR6wtEGFR and NR6W cells has previously been determined and hence NR6wtEGFR and NR6W cells are supplemented with 10 nM and 0.1 nM EGF, respectively. EGF is not added to NR6 and NR6M cells. After 72 hours the amount of cells are measured by performing a MTT proliferation assay.
    (Only for Reference)
Animal Research:[3]
+ Expand
  • Animal Models: Female nude mice (cba nu/nu) aged 8–10 weeks are intra-dermal injected with LoVo cells.
  • Formulation: 0.5% polysorbate
  • Dosages: 100 mg/kg
  • Administration: Once daily by oral administration (0.1 mL/10 g body weight) for 14 days
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 89 mg/mL (199.14 mM)
Ethanol 4 mg/mL (8.95 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order:
1% CMC Na
For best results, use promptly after mixing.
30mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 446.90
Formula

C22H24ClFN4O3

CAS No. 184475-35-2
Storage powder
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03050164 Completed Bioequivalence Study Hunan Kelun Pharmaceutical Co., Ltd. September 8, 2016 Phase 1
NCT02856893 Not yet recruiting NSCLC European Organisation for Research and Treatment of Cancer - EORTC|AstraZeneca March 2017 Phase 2
NCT02976116 Recruiting NSCLC Hutchison Medipharma Limited December 2016 Phase 2
NCT02951637 Not yet recruiting Lung Adenocarcinoma Shanghai Chest Hospital|Ruijin Hospital|Changhai Hospital December 2016 Phase 2
NCT02930954 Not yet recruiting Non-small-cell Lung Cancer Caicun Zhou|Tongji University November 2016 Phase 2
NCT02929693 Enrolling by invitation Cancer Shanghai University of Traditional Chinese Medicine|Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China October 2016 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    I try to dissolve Gefitinib (ZD1839) in 0.5% methylcellulose+0.2% Tween 80 for in vivo experiments. However, when I prepare the mixture, it forms precipitates. Exists another way to dissolve completely the compound?

  • Answer:

    S1025 can be dissovled in both 5% DMSO+corn oil and 5% DMSO+30% PEG 300+5% Tween 80+ddH2O at 2.5 mg/ml clearly. It dissolves in DMSO not readily, please sonicate and warm it in water bath at about 45 degree, and dissolve it clearly first. Then add other solvent.

Related Antibodies

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products

Tags: buy Gefitinib (ZD1839) | Gefitinib (ZD1839) supplier | purchase Gefitinib (ZD1839) | Gefitinib (ZD1839) cost | Gefitinib (ZD1839) manufacturer | order Gefitinib (ZD1839) | Gefitinib (ZD1839) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID